WO2016098965A1 - Antiseptic composition and use thereof - Google Patents

Antiseptic composition and use thereof Download PDF

Info

Publication number
WO2016098965A1
WO2016098965A1 PCT/KR2015/004678 KR2015004678W WO2016098965A1 WO 2016098965 A1 WO2016098965 A1 WO 2016098965A1 KR 2015004678 W KR2015004678 W KR 2015004678W WO 2016098965 A1 WO2016098965 A1 WO 2016098965A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
antiseptic
antiseptic composition
weight
present
Prior art date
Application number
PCT/KR2015/004678
Other languages
French (fr)
Korean (ko)
Inventor
전용석
조희원
최태근
Original Assignee
코오롱생명과학 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코오롱생명과학 주식회사 filed Critical 코오롱생명과학 주식회사
Priority to KR1020177014904A priority Critical patent/KR20170087469A/en
Publication of WO2016098965A1 publication Critical patent/WO2016098965A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/08Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/09Fish posts

Definitions

  • the present invention relates to antiseptic compositions and uses thereof.
  • microorganisms such as bacteria and fungi are not only numerous but also widely distributed in the natural world such as soil, air, water, and seawater, and can be grown and reproduced at any time when growth conditions are suitable. Diseases, food corruption, housing, clothing, industrial products to the damage caused by microorganisms is a serious situation.
  • CMIT chloromethylisothiazolinone
  • IPBC 3-iodo-2-propynylbutylcarbamate
  • BKC Benzalkonium Chloride
  • PHMG polyhexamethylene guanidine
  • PHMB polyhexamethylene biguanide
  • paraben Paraben and alcohol are used as antibacterial and fungicides.
  • CMIT and PHMB are guadiin-based chemicals that cause acute lung injury syndrome caused by a humidifier cleaner, and 3-iodine-2-propynylbutyl.
  • Carbamate is a socially-issued substance that is regulated for infant products by Japan's Ministry of Health, Labor and Welfare, and therefore, development of an antiseptic substance that can replace them is required.
  • Cetylpyridinium Chloride is a quaternary ammonium cation used in mouthwashes, toothpastes, oral sprays, nasal sprays, etc., which has bactericidal effects against bacteria and microorganisms, and prevents plaque from teeth. It is known to reduce gingivitis (Source: www.wikipedia.com).
  • U.S. Patent No. 6,861,047 discloses toothpastes and mouthwashes containing CPC and sodium dihydroacetate
  • Korean Patent Application No. 10-2001-0045337 discloses seed or cultivars of soybeans such as bean sprouts. Disclosed is a method for preventing rot of two vegetables by dipping, spraying or irrigation of CPC.
  • the present inventors conducted a study in order to overcome the problems of the preservatives currently used, as a result of using a mixture of cetylpyridinium chloride and sodium metabisulfite, excellent antibacterial and antifungal power, while increasing the durability, When the freezing point and the recrystallization temperature is low and used in the product, it was confirmed that the skin has a hypoallergenic effect, which is excellent in stability, and completed the present invention.
  • Patent Document 1 US Patent Registration No. 6,861,047
  • Patent Document 2 Korean Patent Application No. 10-2001-0045337
  • An object of the present invention is not irritating skin, harmless to the human body, having the same or more antiseptic force without including components such as CMIT, PHMB, PHMG, Paraben, which may be harmful to the human body, low freezing point and recrystallization temperature
  • the present invention provides an antiseptic composition having improved product stability and a use thereof.
  • the present invention provides an antiseptic composition
  • an antiseptic composition comprising sodium metabisulfite (SDS) and cetylpyridinium chloride (CPC) in a weight ratio of 1: 0.2 to 5.
  • the antiseptic composition may further include any one selected from the group consisting of sodium sulfite, hexylene glycol, surfactants, and combinations thereof.
  • the preservative composition is SDS and sodium sulfite in the case of sodium sulfite 1: 0.1 to 1.5 by weight, SDS and hexylene glycol in the weight ratio of 1: 0.1 to 1.5 for hexylene glycol, SDS and It may include a surfactant 1: 0.1 to 300.
  • the surfactant may be a ionic surfactant of carboxylate, sulfate ester salt, sulfonate salt or phosphate ester salt; Polyethylene glycol-based or polyhydric alcohol-based non-ionic surfactants; And amino acid-based or betaine-based amphoteric surfactants.
  • the antiseptic composition may be one in which the formulation is selected from an aqueous solution, an emulsion, a dispersion, a suspension and a useful solution.
  • the present invention provides a composition for wet wipes comprising the antiseptic composition.
  • the wet wipes composition may include 0.01 wt% to 10 wt% of the antiseptic composition.
  • composition for wet wipes may further include any one selected from the group consisting of glycerin, citric acid, a pH adjusting agent, and combinations thereof.
  • the present invention provides a cosmetic composition comprising the antiseptic composition.
  • the cosmetic composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
  • the cosmetic composition may further include any one selected from the group consisting of cyclopentasiloxane (cyclopentasiloxane), disodium ethane (EDTA-2NA), glycerin, butylene glycol and combinations thereof.
  • cyclopentasiloxane cyclopentasiloxane
  • EDTA-2NA disodium ethane
  • glycerin glycerin
  • butylene glycol butylene glycol
  • the present invention provides a shampoo composition comprising the antiseptic composition.
  • the shampoo composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
  • the shampoo composition may further comprise any one selected from the group consisting of disodium coco ampodiacetate, cocamidopropyl betaine, disodium laureth sulfosuccinate, decyl glucoside, and combinations thereof.
  • the present invention provides a detergent composition comprising the antiseptic composition.
  • the detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
  • the present invention provides a composition for fabric softener comprising the antiseptic composition.
  • the fabric softener composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
  • the present invention provides an industrial detergent composition comprising the antiseptic composition.
  • the industrial detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
  • the antiseptic composition has excellent antibacterial and antifungal activity and persistence, thus protecting the product and the user against microorganisms from external exposure environment, having low skin irritation, harmless to the human body, and treating the antiseptic composition to the product. Not only does not affect the physical and chemical properties of the product, but also has high physical stability such as low temperature stability, high temperature stability and pH stability of the antiseptic composition, which is useful for wet wipes, human cleaners, household cleaners, diapers, hygiene products, cosmetics and disinfectants. Can be used.
  • the present invention relates to an antiseptic composition
  • an antiseptic composition comprising sodium metabisulfite (SDS) and cetylpyridinium chloride (CPC).
  • the antiseptic composition has a sterile or bactericidal effect on microorganisms, and includes both an antibacterial effect on bacteria and an antifungal effect on fungi.
  • the sodium metabisulfite (SDS) is used as an antioxidant and a reducing agent, and the composition of the present invention was confirmed to have excellent antibacterial and antifungal effects by mixing with CPC.
  • SDS has a disadvantage that there is a sulfuric acid odor at less than pH 5.0, in the antiseptic composition of the present invention confirmed the effect of improving the physical stability and odor.
  • the antiseptic composition may include SDS and CPC in a weight ratio of 1: 0.2 to 5, preferably, in a weight ratio of 1: 0.2 to 0.25 or 1: 4 to 5. When it satisfies the weight ratio, it is preferable for stabilizing physical properties and improving antibacterial and antifungal properties of the antiseptic composition.
  • the antiseptic composition may include 0.001 to 20% by weight of sodium metabisulfite, 0.001 to 20% by weight of cetylpyridinium chloride, and a residual amount of purified water.
  • the cetylpyridinium chloride is less than 0.001% by weight relative to the total weight of the antiseptic composition, the antimicrobial and antifungal activity of the target microorganism is reduced, and the antimicrobial agent does not have an antimicrobial spectrum.
  • the physical properties such as low temperature stability, high temperature stability and pH stability in the manufacturing, and it is not suitable for use because of compatibility with other compounds.
  • the sodium metabisulfite is less than 0.001% by weight relative to the total weight of the antiseptic composition, the antimicrobial and antifungal activity of the target microorganism is reduced, and the antimicrobial spectrum has no antimicrobial spectrum. It is difficult to control physical properties such as low temperature stability, high temperature stability and pH stability at the time of manufacture, and it is not suitable for use because it is incompatible with other compounds.
  • the antiseptic composition may further include any one selected from the group consisting of sodium sulfite, hexylene glycol, surfactants, and combinations thereof.
  • the mixing ratio of the SDS and CPC is improved to further improve the antimicrobial and antifungal power of the preservative composition, the freezing point and recrystallization temperature is lowered, and the pH is stabilized to help stabilize the product Excellent effect.
  • SDS and sodium sulfite may be included in a weight ratio of 1: 0.1 to 1.5, preferably 0.5 to 1.5.
  • the content of sodium sulfite is less than 0.1 weight ratio, it is difficult to control the freezing point and recrystallization temperature of the preservative composition, which is a problem in stabilization of the product, and when it exceeds 1.5 weight ratio, it is difficult to control physical properties such as low temperature stability and high temperature stability of the product and stabilize pH. There is a problem.
  • SDS and hexylene glycol may be included in a weight ratio of 1: 0.1 to 1.5, preferably 0.5 to 1.5.
  • the content of sodium sulfite is less than 0.1 weight ratio, it is difficult to control the freezing point and recrystallization temperature of the preservative composition, which is a problem in stabilization of the product, and when it exceeds 1.5 weight ratio, it is difficult to control physical properties such as low temperature stability and high temperature stability of the product and pH. There is a problem with stabilization.
  • the weight ratio of the SDS and the surfactant may include 1: 0.1 to 300, preferably 1: 0.1 to 10. If the content of the surfactant is outside the above range, it is difficult to control the freezing point and recrystallization temperature of the preservative composition and difficult to stabilize the pH, there is a problem in the stabilization of the product.
  • the surfactant can be anionic, non-ionic or amphoteric.
  • the anionic surfactant may be carboxylate, sulfate ester salt, sulfonate salt or phosphate ester salt, and the like, and may be in the form of sodium salt, calcium salt, ammonium salt, ethanolamine salt, and the like. It may be a polyethylene glycol-based or polyhydric alcohol, etc., the amphoteric surfactant may be an amino acid or betaine (betaine) and the like.
  • the anionic surfactants include fatty acid salts, alkyl dicarboxylates, alcohol sulfate ester salts, higher alkyl sulfonates, higher alkyl disulfonates, sulfated fatty acids and fatty acid sulfonated higher fatty acid salts, and higher alkyl phosphoric acid. Ester salt etc. can be illustrated.
  • amphoteric surfactant examples include betaine amphoteric surfactants, glycine amphoteric surfactants, alanine amphoteric surfactants, and sulfobetaine amphoteric surfactants.
  • non-ionic surfactants examples include glycerin esters of higher fatty acids, glycol esters of higher fatty acids, pentaerythritol esters of higher fatty acids, sucrose esters of higher fatty acids, sorbitan and mannitanic ester higher alcohol condensates of higher fatty acids, Higher fatty acid condensates, higher fatty acid amide condensates, higher alkylamine condensates, higher alkyl mercaptan condensates, alkylphenol condensates, polypropylene oxide condensates, and any one selected from the group consisting of It is not limited to.
  • the antiseptic composition may be one in which the formulation is selected from aqueous solutions, emulsions, dispersions, suspensions and useful solutions.
  • the antiseptic composition may further include additives such as perfumes, vegetable extracts, pH adjusting agents, other additives, purified water, thickeners and antioxidants.
  • additives such as perfumes, vegetable extracts, pH adjusting agents, other additives, purified water, thickeners and antioxidants.
  • the antiseptic composition of the present invention is sodium metabisulfite (SDS) and cetylpyridinium chloride (Cetylpyridinium chloride (CPC)), optionally sodium sulfite (Sodium Sulfite), hexylene glycol (Hexylene Glycol), Any one selected from the group consisting of surfactants, additives, and combinations thereof may be prepared by mixing at room temperature, preferably, it is prepared by mixing at 25 ° C. or higher and 80 ° C. or lower, and sonicated to enhance mixing. Or stirring may be performed. In addition, purified water may be prepared by mixing a predetermined amount with these components and stirring or drying after stirring.
  • the present invention relates to a composition for wet wipes comprising the antiseptic composition.
  • the wet wipes composition may include 0.01 wt% to 10 wt% of the antiseptic composition, preferably 0.1 to 1.5 wt%.
  • the content of the antiseptic composition is less than 0.01% by weight, the antibacterial and antifungal effect and persistence is lowered, and when the content exceeds 10% by weight, there is a problem of severe skin irritation or difficult to control physical properties.
  • composition for wet wipes may further include any one selected from the group consisting of a pH adjusting agent, a moisturizing agent, a flavoring agent, and a combination thereof, and preferably, 0.03 to 0.05% by weight of a pH adjusting agent, 0.2 to 0.7% by weight of a moisturizing agent, and 0.01 to 0.01 perfume 0.2 wt%.
  • the moisturizing agent may be used in the field to which the present invention belongs, and examples thereof include glycerin, butylene glycol, natural extracts, skin components, and the like.
  • the pH adjusting agent may be used that is commonly used in the field of the present invention, and examples thereof include citric acid, sodium citrate, lactic acid, sodium hydroxide, potassium hydroxide, tromethamine, tee.
  • the fragrance may be used commonly used in the field to which the present invention belongs, and includes, for example, plant extracts.
  • the wet tissue composition may have a pH of 4.5 to 6.0, preferably pH of 5.0 to 5.8.
  • the wet wipes composition comprising the antiseptic composition of the present invention does not occur sulfuric acid odor by SDS even in the above pH range, it is excellent in low temperature stability of CPC can be used stably without changing the physical properties when manufacturing wet wipes, low skin irritation Has an excellent effect.
  • the present invention relates to a cosmetic composition comprising the antiseptic composition.
  • the cosmetic composition is 0.1% by weight of the antiseptic composition It may be included in 10% by weight, preferably 0.1% to 1.5% by weight. If the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, and when the content of the antiseptic composition is greater than 10% by weight, skin irritation is severe or physical properties are difficult to control, thereby deteriorating physical stability of the cosmetic composition.
  • the cosmetic composition may further include any one selected from the group consisting of pH adjusters, moisturizers, perfumes, surfactants, other additives, purified water, and combinations thereof, depending on the formulation or physical properties of the cosmetic composition to be prepared, preferably 0.01% to 10% by weight of pH adjuster, 0.01% to 30% by weight of moisturizer, 0.01% to 3.0% by weight of perfume, 0.01% to 30% by weight of surfactant, and other additives and purified water.
  • pH adjusters preferably 0.01% to 10% by weight of pH adjuster, 0.01% to 30% by weight of moisturizer, 0.01% to 3.0% by weight of perfume, 0.01% to 30% by weight of surfactant, and other additives and purified water.
  • the present invention relates to a shampoo composition comprising the antiseptic composition.
  • the shampoo composition is 0.1 wt% to the preservative composition 10 It may be included in the weight%, preferably 0.1 to 1.5% by weight. If the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, if the content exceeds 10% by weight of the skin irritation is severe or difficult to control the shampoo properties.
  • the shampoo composition may further include any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, other additives, purified water and combinations thereof.
  • pH adjusters Preferably, 0.01% to 10.0% by weight of pH adjuster, 0.01% to 30% by weight of moisturizer, 0.01% to 3.0% by weight of perfume, 0.01% to 30% by weight of surfactant, and other additives and purified water may be included.
  • the antibacterial and antifungal effect of the present invention is excellent, but the stability of physical properties is excellent.
  • the present invention relates to a composition for detergent comprising the antiseptic composition.
  • the detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition, preferably 0.1 wt% to 1.5 wt%.
  • the content of the antiseptic composition is less than 0.1% by weight, the antibacterial and antifungal effects and persistence is lowered, and when the content of the antiseptic composition exceeds 10% by weight, skin irritation is severe or physical property is difficult to control.
  • the detergent composition may further include any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, antifoaming agents, other additives, purified water, and combinations thereof.
  • pH adjusters Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water.
  • the detergent composition satisfying the above range, while excellent in the antibacterial and antifungal effect of the present invention, there is an effect excellent in the stability of physical properties.
  • the present invention relates to a composition for fabric softener comprising the antiseptic composition.
  • the composition for the fabric softener is 0.1% by weight to the antiseptic composition It may comprise 10% by weight.
  • the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence are inferior, and when the content is greater than 10% by weight, skin irritation is severe or it is difficult to control properties of the fabric softener.
  • the fabric softener composition may further include any one selected from the group consisting of pH adjusters, moisturizers, flavoring agents, surfactants, antifoaming agents, other additives, purified water and combinations thereof.
  • pH adjusters Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water.
  • the antibacterial and antifungal effect of the present invention is excellent, but the stability of physical properties is excellent.
  • the present invention relates to an industrial detergent composition comprising the antiseptic composition.
  • the industrial detergent composition is 0.1% by weight of the antiseptic composition It may be included in 10% by weight, preferably from 0.1% to 5% by weight. When the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, and when the content of the antiseptic composition exceeds 10% by weight, it is difficult to control the physical properties of the industrial cleaning composition.
  • the industrial detergent composition may further include any one selected from the group consisting of the pH adjusting agent, moisturizer, flavoring agent, surfactant, antifoaming agent, other additives, purified water, and combinations thereof.
  • the pH adjusting agent Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water.
  • Industrial cleaning composition satisfying the above range, while excellent in the antibacterial and antifungal effect of the present invention, there is an effect of excellent stability of physical properties.
  • the present invention provides an article comprising the antiseptic composition
  • examples of the article include a diaper, a sanitary ware, a cosmetic, a detergent, an industrial cleaner, a disinfectant, and a hygiene product.
  • the hygiene article may be, for example, oral tissue, mouthwash, shampoo, soap, shower gel, and the like.
  • the article comprises an antiseptic composition of the present invention in an amount of 0.1 wt% to 10 wt% based on the total weight of the article. If the antiseptic composition is less than 0.1% by weight relative to the total weight of the article, the antimicrobial and antifungal effects are insufficient, and when the antiseptic composition is more than 10% by weight, the physical properties of the product and skin irritation may be caused.
  • An article comprising the antiseptic composition of the present invention may be prepared according to a method of manufacturing an article in the field of the present invention, for example, prepared by mixing the antiseptic composition of the present invention as an additional component or preparing an article. In the last step, it can be prepared by the method of treating the preservative composition of the present invention in the article of manufacture.
  • the antiseptic composition may be sprayed onto the article, the antiseptic composition is impregnated with the manufactured article, or at a predetermined stage of the manufactured article manufacturing process. It can process by the method of adding an antiseptic composition and mixing.
  • the article is a cosmetic, it can be prepared by the method of adding the antiseptic composition of the present invention to a certain step of the manufacturing article manufacturing process and mixing using a method such as a stirrer.
  • the antiseptic composition of the present invention may be added to a predetermined step of the manufacturing process of the manufactured article and mixed by using a method such as a stirrer, and may be prepared in a solid or powder state.
  • the preservative composition of the present invention may be added to a predetermined step of the manufacturing process of the manufactured article, and mixed by using a method such as a stirrer, dried, or crushed after drying.
  • the article is a diaper and feminine hygiene products in most cases is made in the form of fibers and can be prepared by the method of adding the impregnated composition of the present invention, impregnated, combined and dried in a certain step of the manufacturing article manufacturing process.
  • Example 7 Example 8
  • Example 9 Example 10 Sodium Metabisulfite 10 10 10 10 10 Cetylpyridinium chloride 40 40 40 40 Sodium sulfite 0 10 0 5 Hexylene glycol 0 0 10 5 Purified water 80 80 80 80 80 80 80
  • Wet tissue compositions were prepared using the antiseptic compositions prepared in Examples 1 to 6 and Comparative Examples 1 and 2 of Table 1.
  • the antiseptic composition shown in Table 1 was added to purified water and stirred, and additionally, flavors, extracts, and moisturizers were added in any order and stirred at room temperature.
  • fragrance 0.01% by weight of citrus flavor, 0.1% by weight of extract of Machi, and 0.5% by weight of glycerin as a moisturizing agent were added. After adding the fragrance, extract and moisturizer, 0.05 wt% of citric acid, sodium citrate and other pH adjusting agents were added as a pH adjusting agent, and the final product was prepared by buffering the pH to 4.8 to 5.8.
  • the wet tissue composition was sprayed onto the fabric using a spray apparatus when the wet tissue fabric passed through the converting machine through the wet tissue manufacturing machine, and the wet tissue fabric was cut to meet the specifications to prepare a wet tissue.
  • No. 9-11 was stirred for 10 minutes at 78 degreeC in 2500 rpm Disper, and No. After stirring 1 ⁇ 8 also at 78 °C, they were mixed with each other for 15 minutes with a Homo mixer at 4000rpm, was stirred at 78 °C. Thereafter, the mixture was slowly cooled, and the emulsion was prepared by uniformly adding the fragrance and the antiseptic composition prepared in Example at a temperature of 40 ° C. or lower.
  • Escherichia coli Esherichia which is a bacterium through Shaking Flask Method coli
  • Staphylococcus aureus Staphylococcus aureus and Pseudomonas aeruginosa
  • 100 mL of nutrient broth Aspergillus niger
  • strains incubated in 100 mL of Potato dextrose Broth were inoculated with platinum.
  • the inoculated medium was incubated at 30 ° C. for 24 hours in a shaking incubator.
  • Example 1 Example 2
  • Example 3 Example 4
  • Example 5 Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 2.5 x 10 6 3 2 2 2 2 One 0 0 2 Staphylococcus aureus 1.5 x 10 6 4 2 2 2 2 One 0 0 2 Pseudomonas aeruginosa 3.1 x 10 6 3 2 2 2 2 One 0 0 3
  • Candida albicans 1.4 x 10 5 4 One One One One One One One One 0 0 2
  • One One One One One One 0 3 Day 3 Escherichia coli 2.5 x 10 6 4 2 0 0 0 0 0 0 2 Staphylococcus aureus 1.5 x 10 6 3 One 0 0 0 0 0 One Pseudomonas aeruginosa 3.1 x 10 6 3 One 0 0 0 0 0 0
  • antibacterial and antiseptic properties are superior to those of SDS or CPC alone.
  • antifungal effect in particular, in the case of the antiseptic composition of Examples 1 to 6 it was confirmed that there are excellent antibacterial and antifungal effect of at least 99.9% in all the various strains within 3 days.
  • examples 5 to 6 it was confirmed that the excellent antibacterial and antifungal effect of at least 99.9% in all the various strains on the second day.
  • the antimicrobial and antifungal effects of the cosmetic composition (emulsion) prepared in Preparation Example 2 were confirmed by the following method.
  • a cosmetic composition emulsion (emulsion) with the ASTM D2574 method Escherichia coli
  • 10 4 CFU / ml Staphylococcus aureus 10 4 CFU / ml Pseudomonas aeroginosa
  • the results were observed after incubation at room temperature for 3 days and 7 days, and streaking candida albicans and Aspergillus niger at 10 5 CFU / ml.
  • Example 11 Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 2.8 x 10 6 3 One 2 One One One 0 0 2 Staphylococcus aureus 1.6 x 10 6 4 One One One One One One 0 0 2 Pseudomonas aeruginosa 2.1 x 10 6 3 One One One One One One One One 0 0 3 Candida albicans 1.6 x 10 5 4 One One One One One One One One One 0 0 2 Black 1.4 x 10 5 4 2 One One One One One One 0 0 4 Day 3 Escherichia coli 2.8 x 10 6 4 3 0 0 0 0 0 0 2 Staphylococcus aureus 1.6 x 10 6 4 2 0 0 0 0 0 2 Pseudomonas aeruginosa 2.1 x 10
  • Examples 1 to 6 of the antiseptic composition of the invention was excellent in the killing rate of more than 99.9% of all bacteria, fungi in the third day, in the cosmetic composition comprising the antiseptic compositions of Comparative Examples 1 and 2 Insufficient antibacterial activity against bacteria and fungi was confirmed to be not completely killed even on day 7.
  • Comparative Example 1 where the content of cetylpyridinium chloride is relatively high, it was confirmed that the antibacterial and antifungal activity was relatively weaker. Therefore, in the case of the antiseptic composition of the present invention, it was confirmed that the SDS and CPC are not simply mixed, but also have an antibacterial and antifungal effect improvement in the weight ratio. In particular, in Examples 5 to 6 antifungal was killed on the second day.
  • Antimicrobial and antifungal effects of the shampoo prepared in Preparation Example 3 were tested in the following manner.
  • Escherichia coli of 10 4 CFU / ml in a shampoo as a target through ASTM D2574 method coli 10 4 CFU / ml Staphylococcus aureus , 10 4 CFU / ml Pseudomonas aeroginosa , streaking and mixed incubation at room temperature for 1, 3, 7 days
  • the antifungal 10 5 CFU / ml Candida albicans and Black fungus Aspergillus niger were also streaking, and the results were observed after incubation at room temperature for 3 days and 7 days.
  • a control (control) was prepared according to Preparation Example 3 by adding the same amount of purified water instead of the preservative composition of the present invention. The test results are shown in Table 12 below.
  • Example 12 Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 2.8 x 10 6 3 One 0 0 0 One One One 2 Staphylococcus aureus 1.8 x 10 6 4 One 0 0 0 One One One One One Pseudomonas aeruginosa 2.9 x 10 6 4 2 0 0 0 One One One One One Candida albicans 1.4 x 10 5 4 3 0 0 One One One One One 3 Black fungus 1.9 x 10 5 4 2 0 0 0 One One One One Day 3 Escherichia coli 2.8 x 10 6 4 3 0 0 0 0 0 0 One Staphylococcus aureus 1.8 x 10 6 4 2 0 0 0 0 0 0 0 One Pseudomonas aeruginosa
  • the antimicrobial and antifungal effect of the laundry detergent prepared in Preparation Example 4 was confirmed by the following method.
  • Escherichia coli of 10 6 CFU / ml in a detergent as a target through ASTM D2574 method coli ), 10 6 CFU / ml Staphylococcus aureus and 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, and the results were observed after incubation at room temperature for 3 days and 7 days.
  • Example 13 Elapsed date Test strain Inoculation number Control Comparative Example 1
  • Example 2 Example 3
  • Example 4 Example 5
  • Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 3.3 x 10 6 2 One 0 0 0 0 0 One 2 Staphylococcus aureus 2.8 x 10 6 3 One 0 0 0 0 0 0 One Pseudomonas aeruginosa 2.1 x 10 6 3 2 0 0 0 0 0 0 0 One Candida albicans 2.4 x 10 5 3 3 0 0 One 0 One One One 3 Black fungus 3.2 x 10 5 4 2 0 0 One One One One Day 3 Escherichia coli 3.3 x 10 6 4 One 0 0 0 0 0 0 One Staphylococcus aureus 2.8 x 10 6 4 0 0 0 0 0 0 0 0 One Pse
  • the antimicrobial and antifungal effects of the fabric softener prepared in Preparation Example 5 were tested in the following manner.
  • Escherichia coli of 10 6 CFU / ml in a detergent as a target through ASTM D2574 method coli ), 10 6 CFU / ml Staphylococcus aureus and 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, and the results were observed after incubation at room temperature for 3 days and 7 days.
  • Example 14 Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 2.5 x 10 6 2 2 0 0 0 0 0 One 2 Staphylococcus aureus 2.1 x 10 6 2 2 0 0 0 0 0 2 Pseudomonas aeruginosa 4.2 x 10 6 2 2 0 0 0 0 0 0 2 Candida albicans 1.9 x 10 5 2 One 0 0 One One One One 3 Black fungus 3.5 x 10 5 4 2 0 0 One One One One Day 3 Escherichia coli 2.5 x 10 6 2 2 0 0 0 0 0 0 2 Staphylococcus aureus 2.1 x 10 6 One One 0 0 0 0 0 0 One Pseudomonas aeruginosa 4.2
  • the antibacterial and antifungal effects of the industrial degreaser remover prepared in Preparation Example 6 were tested in the following manner.
  • 10 6 CFU / ml Escherichia coli , 10 6 CFU / ml Staphylococcus aureus , 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, respectively, and the results were observed after incubation at room temperature for the initial, 3 and 7 days, and 10 5 CFU / ml of candida albicans and black mold
  • the bacteria Aspergillus niger
  • were also streaking and the results were observed after incubation at room temperature for the initial, 1, 3, and 7 days.
  • a control was used to prepare an industrial degreaser removed according to Preparation Example 6 by adding the same amount of purified water instead of the preservative composition of the present invention, the test results are shown in Table 15.
  • Example 1 Example 2
  • Example 3 Example 4
  • Example 6 Comparative Example 2 Strain (CFU / ml) Day 2 Escherichia coli 3.5 x 10 6 3 3 0 One 0 0 0 0 2 Staphylococcus aureus 2.3x 10 6 3 3 One One One One 0 0 2 Pseudomonas aeruginosa 4.1 x 10 6 3 2 0 One 0 0 0 0 2 Candida albicans 1.9 x 10 5 3 3 One One One One One One 0 0 3 Black fungus 3.8 x 10 5 4 3 One One One One One 0 0 One Day 3 Escherichia coli 3.5 x 10 6 3 2 0 0 0 0 0 2 Staphylococcus aureus 2.3x 10 6 2 One 0 0 0 0 0 0 One Pseudomonas aeruginosa 4.1 x 10 6 3 3 0 One 0 0 0 2
  • the temperature (recrystallization temperature) of the fine crystal cloud of the cloud-shaped cloud phenomenon was measured by dropping the temperature with the cooling water with respect to the 100 ml solution. These results are shown in Table 16 below.
  • Example 7 2.0 10.0
  • Example 15 -22.0 0.1
  • Example 8 -3.0 7.0
  • Example 16 -21.0 0.3
  • Example 9 -11.0 6.0
  • Example 17 -22.0 0.3
  • Example 10 -14.0 4.0
  • Example 18 -23.0 0.1
  • Example 11 -15.0 2.0
  • Example 19 -22.0 0.3
  • Example 12 -16.0 1.5
  • Example 20 -22.0 0.2
  • Example 13 -16.5 1.0
  • Example 21 -21.0 0.5
  • Example 14 -20.0 0.5
  • Example 22 -21.0 0.5
  • the antiseptic composition of the present invention may be a formulation selected from an aqueous solution, an emulsion, a disperse, a suspension and a useful solution, the antiseptic composition is a wet wipes composition, cosmetic composition, shampoo composition, detergent composition, fabric softener composition, industrial It can be used in detergent compositions and the like.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to an antiseptic composition exhibiting antibacterial and antifungal activities without causing skin irritation. Wet wipes, cleaning agents for the human body, cleaning agents for household products, diapers, hygiene products, cosmetic products, sanitizers, and the like using the antiseptic composition of the present invention exhibit excellent antibacterial and antifungal activities without causing skin irritation, and the stability of the antiseptic composition is high.

Description

방부 조성물 및 이의 용도Antiseptic composition and use thereof
본 발명은 방부 조성물 및 이의 용도에 관한 것이다.The present invention relates to antiseptic compositions and uses thereof.
현재 일상 생활에서 세균이나 곰팡이 등의 미생물은 그 종류가 대단히 많을 뿐만 아니라 토양, 대기, 물, 해수 등의 자연계에 광범위하게 분포하고 있으며 생육조건이 맞으면 언제든지 생장, 번식이 가능하므로, 미생물에 의한 인간의 질병, 음식물의 부패, 주거, 의복, 공업제품에 이르기까지 미생물에 의한 피해가 심각한 실정이다. In today's daily life, microorganisms such as bacteria and fungi are not only numerous but also widely distributed in the natural world such as soil, air, water, and seawater, and can be grown and reproduced at any time when growth conditions are suitable. Diseases, food corruption, housing, clothing, industrial products to the damage caused by microorganisms is a serious situation.
이의 방지 대책에 대한 연구가 활발히 진행되고 있으며, 구체적으로 기저귀, 물티슈, 위생용품, 화장품, 세정제, 살균제 제품 등에 번식하는 미생물을 제거하거나 발생을 억제하기 위하여, 클로로메틸이소치아졸리논(Chloromethylisothiazolinone:CMIT), 3-요오드-2-프로파이닐부틸카바메이트(3-lodo-2-propynylbutylcarbamate:IPBC), 벤잘코니윰클로라이드(Benzalkonium Chloride: BKC), PHMG(polyhexamethylene guanidine), PHMB(polyhexamethylene biguanide), 파라벤(Paraben), 알코올(Alchol) 등을 항균, 진균제로 사용하고 있다.In order to prevent the occurrence of microorganisms in breeding diapers, wet wipes, hygiene products, cosmetics, detergents, disinfectant products, etc., research is being actively carried out, and chloromethylisothiazolinone (CMIT) ), 3-iodo-2-propynylbutylcarbamate (IPBC), Benzalkonium Chloride (BKC), PHMG (polyhexamethylene guanidine), PHMB (polyhexamethylene biguanide), paraben Paraben and alcohol are used as antibacterial and fungicides.
보다 구제적으로 현재 생산되는 유아용, 성인용 물티슈의 대부분이 CMIT와 PHMB을 사용하고 있으며 보조성분으로 3-요오드-2-프로파이닐부틸카바메이트를 주로 사용하고 있다. 그러나 이러한 물질은 피부자극성이 강하며, PHMG, PHMB 및 PGH는 최근 문제가 된 가습기용 세정제에 의한 급성폐손상 증후군의 원인 물질인 구아디닌계 화학물질이고, 3-요오드-2-프로파이닐부틸카바메이트는 유해성으로 일본 후생성에서 유아용 제품에 규제하는 등 사회적으로 이슈된 물질이므로, 이들을 대체할 수 있는 방부의 물질의 개발이 요구되고 있다. More specifically, most of the wet and adult wipes currently produced use CMIT and PHMB, and 3-iodine-2-propynylbutyl carbamate is mainly used as an auxiliary ingredient. However, these substances have strong skin irritation, and PHMG, PHMB and PGH are guadiin-based chemicals that cause acute lung injury syndrome caused by a humidifier cleaner, and 3-iodine-2-propynylbutyl. Carbamate is a socially-issued substance that is regulated for infant products by Japan's Ministry of Health, Labor and Welfare, and therefore, development of an antiseptic substance that can replace them is required.
염화 세틸피리디늄(Cetylpyridinium Chloride, CPC)은 구강청결제, 치약, 구강스프레이, 비강스프레이 등에 사용되는 4차암모늄 양이온으로서, 박테리아와 미생물들에 대하여 살균효과가 있으며, 치아의 플라그(plaque)를 방지하고, 치은염을 감소시키는 효과가 있다고 알려져 있다(출처: www.wikipedia.com). 이와 관련하여, 미국특허 등록 제6,861,047호에는 CPC 및 디하이드로아세트산 나트륨을 포함하는 치약, 구강청결제가 공지되어 있으며, 한국특허출원 제10-2001-0045337호에는 콩나물과 같은 두채류의 종자나 재배 중에 CPC를 침지, 분사 또는 관수하여 두채류의 부패병을 예방하는 방법이 개시되어 있다. 또한, 국제출원 PCT/US2000/011425호에는 CPC 및 베헨트리늄 메토설페이트 및 스테아릴 알콜(Behentrimonium methosulfate & stearyl alcohol) 쿠아터리늄(Quaterinium), 세트리모니움 클로라이드(Cetrimonium chloride)의 4가지 성분을 함유하는 기저귀, 위생용 티슈 및 물티슈 상품군에서 선택된 섬유위생용품이 개시되어 있다. 그러나, CPC는 정제수에 용해시킬 때 약 15 에서 얼기 시작하며, 약 13에서 재결정화가 시작되는 문제점을 가지고 있기에, 정제수를 용매로 사용하였을 경우에 제품화하는데 문제점이 있다.Cetylpyridinium Chloride (CPC) is a quaternary ammonium cation used in mouthwashes, toothpastes, oral sprays, nasal sprays, etc., which has bactericidal effects against bacteria and microorganisms, and prevents plaque from teeth. It is known to reduce gingivitis (Source: www.wikipedia.com). In this regard, U.S. Patent No. 6,861,047 discloses toothpastes and mouthwashes containing CPC and sodium dihydroacetate, and Korean Patent Application No. 10-2001-0045337 discloses seed or cultivars of soybeans such as bean sprouts. Disclosed is a method for preventing rot of two vegetables by dipping, spraying or irrigation of CPC. In addition, International Application PCT / US2000 / 011425 discloses four components: CPC, behentrinium methosulfate and stearyl alcohol, quaterinium, and cetrimonium chloride. Disclosed are a textile hygiene product selected from the group of diapers, hygienic tissues, and wet tissue products. However, since CPC starts to freeze at about 15 when dissolved in purified water and recrystallization starts at about 13, CPC has a problem in commercialization when purified water is used as a solvent.
이에, 본 발명자들은 현재 사용되고 있는 방부제의 문제점을 극복하기 위하여, 연구를 수행한 결과 염화 세틸피리디늄과 소듐 메타바이설파이트를 혼합하여 사용하는 경우 항균력 및 항진균력이 우수하고, 지속성이 높아지면서도, 빙점 및 재결정 온도가 낮아 제품에 사용하였을 경우 안정성이 우수한, 피부 저자극성 효과가 있음을 확인하여, 본 발명을 완성하였다. Thus, the present inventors conducted a study in order to overcome the problems of the preservatives currently used, as a result of using a mixture of cetylpyridinium chloride and sodium metabisulfite, excellent antibacterial and antifungal power, while increasing the durability, When the freezing point and the recrystallization temperature is low and used in the product, it was confirmed that the skin has a hypoallergenic effect, which is excellent in stability, and completed the present invention.
[선행기술문헌][Preceding technical literature]
[특허문헌][Patent Documents]
(특허문헌 1) 미국특허등록 제 6,861,047호(Patent Document 1) US Patent Registration No. 6,861,047
(특허문헌 2) 한국특허출원 제10-2001-0045337호(Patent Document 2) Korean Patent Application No. 10-2001-0045337
본 발명의 목적은 피부자극성이 없고, 인체에 무해하면서도, 인체 유해한 성분일 수 있는 CMIT, PHMB, PHMG, Paraben 등의 성분을 포함하지 않고도 동일 또는 그 이상의 방부력을 가지며, 빙점 및 재결정 온도가 낮아 제품 안정성이 개선된 방부 조성물 및 이를 이용한 용도를 제공하는 것이다.An object of the present invention is not irritating skin, harmless to the human body, having the same or more antiseptic force without including components such as CMIT, PHMB, PHMG, Paraben, which may be harmful to the human body, low freezing point and recrystallization temperature The present invention provides an antiseptic composition having improved product stability and a use thereof.
본 발명은 소듐 메타바이설파이트(Sodium Metabisulfite, SDS) 및 염화 세틸피리디늄(Cetylpyridinium chloride, CPC)을 중량비 1 : 0.2 내지 5로 포함하는 방부 조성물을 제공한다. The present invention provides an antiseptic composition comprising sodium metabisulfite (SDS) and cetylpyridinium chloride (CPC) in a weight ratio of 1: 0.2 to 5.
상기 방부 조성물은 소듐설파이트(Sodium Sulfite), 헥실렌글라이콜(Hexylene Glycol), 계면활성제 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. The antiseptic composition may further include any one selected from the group consisting of sodium sulfite, hexylene glycol, surfactants, and combinations thereof.
상기 방부 조성물은 소듐설파이트의 경우 SDS와 소듐설파이트는 중량비 1 : 0.1 내지 1.5, 헥실렌글라이콜의 경우 SDS와 헥실렌글라이콜을 중량비 1 : 0.1 내지 1.5, 계면활성제의 경우 SDS와 계면활성제를 1 : 0.1 내지 300으로 포함할 수 있다. The preservative composition is SDS and sodium sulfite in the case of sodium sulfite 1: 0.1 to 1.5 by weight, SDS and hexylene glycol in the weight ratio of 1: 0.1 to 1.5 for hexylene glycol, SDS and It may include a surfactant 1: 0.1 to 300.
상기 계면활성제는 카르본산염계, 황산에스테르염계, 설폰산염계 또는 인산에스테르염계의 이온성 계면활성제; 폴리에틸렌글리콜계 또는 다가알코올계의 비-이온성 계면활성제; 및 아미노산계 또는 베타인계(Betaine)의 양쪽성 계면활성제일 수 있다.The surfactant may be a ionic surfactant of carboxylate, sulfate ester salt, sulfonate salt or phosphate ester salt; Polyethylene glycol-based or polyhydric alcohol-based non-ionic surfactants; And amino acid-based or betaine-based amphoteric surfactants.
상기 방부 조성물은 제형이 수용액, 에멀전, 디스퍼전(dispersion), 서스펜션(suspension) 및 유용액 중에서 선택된 것일 수 있다. The antiseptic composition may be one in which the formulation is selected from an aqueous solution, an emulsion, a dispersion, a suspension and a useful solution.
본 발명의 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 물티슈용 조성물을 제공한다. According to another embodiment of the present invention, the present invention provides a composition for wet wipes comprising the antiseptic composition.
상기 물티슈용 조성물은 상기 방부 조성물을 0.01 중량% 내지 10 중량%로 포함하는 것일 수 있다. The wet wipes composition may include 0.01 wt% to 10 wt% of the antiseptic composition.
상기 물티슈용 조성물은 글리세린, 구연산, pH 조절제 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다.The composition for wet wipes may further include any one selected from the group consisting of glycerin, citric acid, a pH adjusting agent, and combinations thereof.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 화장료 조성물을 제공한다. According to another embodiment of the present invention, the present invention provides a cosmetic composition comprising the antiseptic composition.
상기 화장료 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다. The cosmetic composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
상기 화장료 조성물은 사이클로펜타실록산(cyclopentasiloxane), 디소듐이디티에이(EDTA-2NA), 글리세린, 부틸렌글라이콜 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. The cosmetic composition may further include any one selected from the group consisting of cyclopentasiloxane (cyclopentasiloxane), disodium ethane (EDTA-2NA), glycerin, butylene glycol and combinations thereof.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 샴푸 조성물을 제공한다.According to another embodiment of the present invention, the present invention provides a shampoo composition comprising the antiseptic composition.
상기 샴푸 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다.The shampoo composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
상기 샴푸 조성물은 조성물은 디소듐코코암포디아세테이트, 코카미도프로필베타인, 디소퓸라우레스설포석시네이트, 데실글루코사이드 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다.The shampoo composition may further comprise any one selected from the group consisting of disodium coco ampodiacetate, cocamidopropyl betaine, disodium laureth sulfosuccinate, decyl glucoside, and combinations thereof.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 세제용 조성물을 제공한다. According to another embodiment of the present invention, the present invention provides a detergent composition comprising the antiseptic composition.
상기 세제용 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다. The detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 섬유유연제용 조성물을 제공한다. According to another embodiment of the present invention, the present invention provides a composition for fabric softener comprising the antiseptic composition.
상기 섬유유연제용 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다. The fabric softener composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 산업용 세정제 조성물을 제공한다. According to another embodiment of the present invention, the present invention provides an industrial detergent composition comprising the antiseptic composition.
상기 산업용 세정제 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다. The industrial detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition.
기타 본 발명의 구현예들의 구체적인 사항은 이하의 상세한 설명에 포함되어 있다.Other specific details of embodiments of the present invention are included in the following detailed description.
본 발명에 방부 조성물의 경우 항균 및 항진균 활성과 지속력이 우수하여 외부 노출 환경으로부터 미생물에 대한 제품 및 사용자를 보호하는 효과가 있고, 피부 자극성이 낮고, 인체에 무해하며, 방부 조성물을 제품에 처리시 제품의 물리적 화학적 성질에 영향을 주지 않을 뿐만 아니라, 방부 조성물의 저온안정성, 고온안정성 및 pH안정성 등의 물성 안정성이 높아 물티슈, 인체 세정제, 생활용품 세정제, 기저귀, 위생용품, 화장품 및 살균제 등에 유용하게 사용될 수 있다.In the present invention, the antiseptic composition has excellent antibacterial and antifungal activity and persistence, thus protecting the product and the user against microorganisms from external exposure environment, having low skin irritation, harmless to the human body, and treating the antiseptic composition to the product. Not only does not affect the physical and chemical properties of the product, but also has high physical stability such as low temperature stability, high temperature stability and pH stability of the antiseptic composition, which is useful for wet wipes, human cleaners, household cleaners, diapers, hygiene products, cosmetics and disinfectants. Can be used.
본 발명은 소듐 메타바이설파이트(Sodium Metabisulfite, SDS) 및 염화 세틸피리디늄(Cetylpyridinium chloride, CPC)를 포함하는 방부 조성물에 관한 것이다. The present invention relates to an antiseptic composition comprising sodium metabisulfite (SDS) and cetylpyridinium chloride (CPC).
상기 방부 조성물은 미생물에 대한 멸균 또는 살균 효과를 갖는 것으로, 세균에 대한 항균 효과 및 진균에 대한 항진균 효과를 모두 포함하는 것이다. The antiseptic composition has a sterile or bactericidal effect on microorganisms, and includes both an antibacterial effect on bacteria and an antifungal effect on fungi.
상기 소듐 메타바이설파이트(SDS)는 산화방지제, 환원제로 사용되는 것으로, 본 발명의 조성물에서는 CPC와 혼합하여 항균 및 항진균 효과가 우수함을 확인 하였다. 특히 SDS는 pH 5.0 미만에서 황산취가 있는 단점이 있으나, 본 발명의 방부 조성물에서는 물성 안정성 및 냄새가 개선되는 효과를 확인하였다. The sodium metabisulfite (SDS) is used as an antioxidant and a reducing agent, and the composition of the present invention was confirmed to have excellent antibacterial and antifungal effects by mixing with CPC. In particular, SDS has a disadvantage that there is a sulfuric acid odor at less than pH 5.0, in the antiseptic composition of the present invention confirmed the effect of improving the physical stability and odor.
상기 방부 조성물은 SDS와 CPC를 중량비 1 : 0.2 내지 5로 포함할 수 있고, 바람직하게는 1: 0.2 내지 0.25 또는 1 : 4 내지 5의 중량비로 포함할 수 있다. 상기 중량비를 만족하여 포함하는 경우, 물성 안정화 및 방부 조성물의 항균 및 항진균 향상에 바람직하다. The antiseptic composition may include SDS and CPC in a weight ratio of 1: 0.2 to 5, preferably, in a weight ratio of 1: 0.2 to 0.25 or 1: 4 to 5. When it satisfies the weight ratio, it is preferable for stabilizing physical properties and improving antibacterial and antifungal properties of the antiseptic composition.
상기 방부 조성물은, 소듐 메타바이설파이트 0.001 내지 20 중량%, 염화 세틸피리디늄 0.001 내지 20 중량% 및 잔량의 정제수를 포함할 수 있다. The antiseptic composition may include 0.001 to 20% by weight of sodium metabisulfite, 0.001 to 20% by weight of cetylpyridinium chloride, and a residual amount of purified water.
상기 염화 세틸피리디늄이 방부 조성물 총 중량 대비 0.001 중량% 미만이면 대상 미생물에 대한 항균 및 항진균력이 떨어지고, 넒은 항균 스펙트럼을 가지지 못하며, 20 중량%를 초과하는 경우 인체에 대한 피부 독성 및 생리 기능에 이상이 있을 수 있고, 제조시 저온안정성, 고온안정성 및 pH안정성 등의 물성 조절이 어려우며, 다른 화합물과 상용성이 떨어져 사용하기에 부적합하다.If the cetylpyridinium chloride is less than 0.001% by weight relative to the total weight of the antiseptic composition, the antimicrobial and antifungal activity of the target microorganism is reduced, and the antimicrobial agent does not have an antimicrobial spectrum. There may be the above, it is difficult to control the physical properties such as low temperature stability, high temperature stability and pH stability in the manufacturing, and it is not suitable for use because of compatibility with other compounds.
상기 소듐 메타바이설파이트가 방부 조성물 총 중량 대비 0.001 중량% 미만이면 대상 미생물에 대한 항균 및 항진균력이 떨어지고, 넒은 항균 스펙트럼을 가지지 못하며, 20 중량%를 초과하는 경우 인체에 대한 피부 자극의 우려가 있고, 제조시 저온안정성, 고온안정성 및 pH안정성 등의 물성 조절이 어려우며, 다른 화합물과 상용성이 떨어져 사용하기에 부적합하다.If the sodium metabisulfite is less than 0.001% by weight relative to the total weight of the antiseptic composition, the antimicrobial and antifungal activity of the target microorganism is reduced, and the antimicrobial spectrum has no antimicrobial spectrum. It is difficult to control physical properties such as low temperature stability, high temperature stability and pH stability at the time of manufacture, and it is not suitable for use because it is incompatible with other compounds.
상기 방부 조성물은 소듐설파이트(Sodium Sulfite), 헥실렌글라이콜(Hexylene Glycol), 계면활성제 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. 상기 성분을 더 포함하는 경우, SDS와 CPC의 혼합률이 개선되어 방부 조성물의 항균 및 항진균력을 더욱 향상시킬 수 있고, 빙점 및 재결정 온도가 낮아지고, pH의 안정화에 도움이 되어 제품의 안정성이 우수한 효과가 있다. The antiseptic composition may further include any one selected from the group consisting of sodium sulfite, hexylene glycol, surfactants, and combinations thereof. When further comprising the component, the mixing ratio of the SDS and CPC is improved to further improve the antimicrobial and antifungal power of the preservative composition, the freezing point and recrystallization temperature is lowered, and the pH is stabilized to help stabilize the product Excellent effect.
상기 소듐설파이트의 경우 SDS와 소듐설파이트는 중량비 1 : 0.1 내지 1.5로 포함될 수 있고, 바람직하게 0.5 내지 1.5로 포함될 수 있다. 상기 소듐설파이트의 함량이 0.1 중량비 미만인 경우 방부 조성물의 빙점 및 재결정 온도의 조절이 어려워 제품의 안정화에 문제가 되고, 1.5 중량비 초과하는 경우 제품의 저온안정성, 고온안정성 등과 같은 물성 조절이 어렵고 pH 안정화에 문제가 있다. In the case of the sodium sulfite, SDS and sodium sulfite may be included in a weight ratio of 1: 0.1 to 1.5, preferably 0.5 to 1.5. When the content of sodium sulfite is less than 0.1 weight ratio, it is difficult to control the freezing point and recrystallization temperature of the preservative composition, which is a problem in stabilization of the product, and when it exceeds 1.5 weight ratio, it is difficult to control physical properties such as low temperature stability and high temperature stability of the product and stabilize pH. There is a problem.
상기 헥실렌글라이콜의 경우 SDS와 헥실렌글라이콜을 중량비 1: 0.1 내지 1.5로 포함될 수 있고, 바람직하게 0.5 내지 1.5로 포함될 수 있다. 상기 소듐설파이트의 함량이 0.1 중량비 미만인 경우 방부 조성물의 빙점 및 재결정 온도의 조절이 어려워 제품의 안정화에 문제가 되고, 1.5 중량비를 초과하는 경우 제품의 저온안정성, 고온안정성 등과 같은 물성 조절이 어렵고 pH 안정화에 문제가 있다. In the case of hexylene glycol, SDS and hexylene glycol may be included in a weight ratio of 1: 0.1 to 1.5, preferably 0.5 to 1.5. When the content of sodium sulfite is less than 0.1 weight ratio, it is difficult to control the freezing point and recrystallization temperature of the preservative composition, which is a problem in stabilization of the product, and when it exceeds 1.5 weight ratio, it is difficult to control physical properties such as low temperature stability and high temperature stability of the product and pH. There is a problem with stabilization.
상기 계면활성제의 경우, SDS와 계면활성제의 중량비가 1: 0.1 내지 300, 바람직하게 1: 0.1 내지 10으로 포함할 수 있다. 상기 계면활성제의 함량이 상기 범위를 벗어나는 경우, 방부 조성물의 빙점 및 재결정 온도의 조절이 어렵고 pH 안정화에 어려워 제품의 안정화에 문제가 있다.In the case of the surfactant, the weight ratio of the SDS and the surfactant may include 1: 0.1 to 300, preferably 1: 0.1 to 10. If the content of the surfactant is outside the above range, it is difficult to control the freezing point and recrystallization temperature of the preservative composition and difficult to stabilize the pH, there is a problem in the stabilization of the product.
상기 계면활성제는 음이온성, 비-이온성 또는 양쪽성일 수 있다. 상기 음이온성 계면활성제는 카르본산염계, 황산에스테르염계, 설폰산염계 또는 인산에스테르염계 등일 수 있으며 나트륨염, 칼슘염, 암모늄염, 에탄올아민염 등의 형태가 가능하고, 비-이온성 계면활성제는 폴리에틸렌글리콜계 또는 다가알코올계 등일 수 있으며, 상기 양쪽성 계면활성제는 아미노산계 또는 베타인계(Betaine) 등일 수 있다.The surfactant can be anionic, non-ionic or amphoteric. The anionic surfactant may be carboxylate, sulfate ester salt, sulfonate salt or phosphate ester salt, and the like, and may be in the form of sodium salt, calcium salt, ammonium salt, ethanolamine salt, and the like. It may be a polyethylene glycol-based or polyhydric alcohol, etc., the amphoteric surfactant may be an amino acid or betaine (betaine) and the like.
더욱 구체적으로, 상기 음이온 계면활성제의 종류에는 지방산염, 알킬디카르복시산염, 알코올 황산에스테르염, 고급 알킬술폰산염, 고급 알킬디술폰산염, 황산화지방 및 지방산염 술폰화 고급 지방산염, 고급 알킬인산에스테르염 등을 예시할 수 있다.More specifically, the anionic surfactants include fatty acid salts, alkyl dicarboxylates, alcohol sulfate ester salts, higher alkyl sulfonates, higher alkyl disulfonates, sulfated fatty acids and fatty acid sulfonated higher fatty acid salts, and higher alkyl phosphoric acid. Ester salt etc. can be illustrated.
상기 양쪽성 계면활성제의 종류에는 베타인형 양쪽성 계면활성제, 글리신형 양쪽성 계면활성제, 알라닌형 양쪽성 계면활성제, 술포베타인형 양쪽성 계면활성제가 있다.Examples of the amphoteric surfactant include betaine amphoteric surfactants, glycine amphoteric surfactants, alanine amphoteric surfactants, and sulfobetaine amphoteric surfactants.
상기 비-이온성 계면활성제의 종류에는 고급 지방산의 글리세린에스테르, 고급 지방산의 글리콜에스테르, 고급 지방산의 펜타에리트리톨에스테르, 고급 지방산의 자당에스테르, 고급 지방산의 소르비탄 및 만니탄에스테르 고급 알코올 축합물, 고급 지방산 축합물, 고급 지방산아미드 축합물, 고급 알킬아민 축합물, 고급 알킬메르캅탄 축합물, 알킬페놀 축합물, 폴리프로필렌옥사이드 축합물 이들의 혼합물로 이루어진 군에서 선택되는 어느 하나를 포함하나, 이들로 제한되지는 않는다.Examples of the non-ionic surfactants include glycerin esters of higher fatty acids, glycol esters of higher fatty acids, pentaerythritol esters of higher fatty acids, sucrose esters of higher fatty acids, sorbitan and mannitanic ester higher alcohol condensates of higher fatty acids, Higher fatty acid condensates, higher fatty acid amide condensates, higher alkylamine condensates, higher alkyl mercaptan condensates, alkylphenol condensates, polypropylene oxide condensates, and any one selected from the group consisting of It is not limited to.
상기 방부 조성물은 제형이 수용액, 에멀전, 디스퍼전(dispersion), 서스펜션(suspension) 및 유용액 중에서 선택된 것 일 수 있다. The antiseptic composition may be one in which the formulation is selected from aqueous solutions, emulsions, dispersions, suspensions and useful solutions.
상기 방부 조성물의 경우 향료, 식물성 추출물, pH 조절제, 기타 첨가제, 정제수, 증점제 및 항산화제 등의 첨가제를 더 포함할 수 있다. The antiseptic composition may further include additives such as perfumes, vegetable extracts, pH adjusting agents, other additives, purified water, thickeners and antioxidants.
본 발명의 방부 조성물은 소듐 메타바이설파이트(Sodium Metabisulfite, SDS) 및 염화 세틸피리디늄(Cetylpyridinium chloride, CPC)과, 선택적으로 소듐설파이트(Sodium Sulfite), 헥실렌글라이콜(Hexylene Glycol), 계면활성제, 첨가제 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 실온에서 혼합하여 제조할 수 있고, 바람직하게는 25℃ 이상 80℃ 이하에서 혼합하여 제조하는 것이 바람직하고, 혼합을 증진시키기 위해 초음파 처리 또는 교반 등을 할 수 있다. 또한 정제수를 이들 성분에 일정량 혼합하여 교반하거나 교반 후 건조 처리하여 제조할 수 있다. The antiseptic composition of the present invention is sodium metabisulfite (SDS) and cetylpyridinium chloride (Cetylpyridinium chloride (CPC)), optionally sodium sulfite (Sodium Sulfite), hexylene glycol (Hexylene Glycol), Any one selected from the group consisting of surfactants, additives, and combinations thereof may be prepared by mixing at room temperature, preferably, it is prepared by mixing at 25 ° C. or higher and 80 ° C. or lower, and sonicated to enhance mixing. Or stirring may be performed. In addition, purified water may be prepared by mixing a predetermined amount with these components and stirring or drying after stirring.
본 발명의 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 물티슈용 조성물에 관한 것이다.According to another embodiment of the present invention, the present invention relates to a composition for wet wipes comprising the antiseptic composition.
상기 물티슈용 조성물은 상기 방부 조성물을 0.01 중량% 내지 10 중량%로 포함하고, 바람직하게 0.1 내지 1.5 중량%로 포함하는 것일 수 있다. 상기 방부 조성물의 함량이 0.01 중량% 미만인 경우, 항균 및 항진균 효과 및 지속성이 떨어지고, 상기 중량 10 중량%를 초과하는 경우 피부 자극이 심하거나 물성 조절이 어려운 문제가 있다. The wet wipes composition may include 0.01 wt% to 10 wt% of the antiseptic composition, preferably 0.1 to 1.5 wt%. When the content of the antiseptic composition is less than 0.01% by weight, the antibacterial and antifungal effect and persistence is lowered, and when the content exceeds 10% by weight, there is a problem of severe skin irritation or difficult to control physical properties.
상기 물티슈용 조성물은 pH 조절제, 보습제, 향료 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있고, 바람직하게는 pH 조절제 0.03 내지 0.05 중량%, 보습제 0.2 내지 0.7 중량% 및 향료 0.01 내지 0.2 중량%로 포함할 수 있다.The composition for wet wipes may further include any one selected from the group consisting of a pH adjusting agent, a moisturizing agent, a flavoring agent, and a combination thereof, and preferably, 0.03 to 0.05% by weight of a pH adjusting agent, 0.2 to 0.7% by weight of a moisturizing agent, and 0.01 to 0.01 perfume 0.2 wt%.
상기 보습제는 본 발명이 속하는 분야에서 통상적으로 사용되는 것을 이용할 수 있고, 일 예로 글리세린, 부틸렌글라이콜, 천연추출물, 피부 구성 성분 등을 포함한다. The moisturizing agent may be used in the field to which the present invention belongs, and examples thereof include glycerin, butylene glycol, natural extracts, skin components, and the like.
상기 pH 조절제로는 본 발명이 속하는 분야에서 통상적으로 사용되는 것을 이용할 수 있고, 일 예로 구연산, 구연산 나트륨, 젖산, 수산화나트륨, 수산화칼륨, 트로메타민, 티이에이 등을 포함한다. The pH adjusting agent may be used that is commonly used in the field of the present invention, and examples thereof include citric acid, sodium citrate, lactic acid, sodium hydroxide, potassium hydroxide, tromethamine, tee.
상기 향료로는 본 발명이 속하는 분야에서 통상적으로 사용되는 것을 이용할 수 있고, 일 예로 식물 추출물을 포함한다. The fragrance may be used commonly used in the field to which the present invention belongs, and includes, for example, plant extracts.
상기 물티슈용 조성물은 pH가 4.5 내지 6.0, 바람직하게는 pH가 5.0 내지 5.8일 수 있다. 본 발명의 방부 조성물을 포함하는 물티슈용 조성물의 경우 상기 pH 범위에서도 SDS에 의한 황산취가 나지 않고, CPC의 저온 안정성이 우수하여 물티슈 제조 시 물성의 변화 없이 안정적으로 사용할 수 있고, 피부 자극도 낮아 우수한 효과를 갖는다. The wet tissue composition may have a pH of 4.5 to 6.0, preferably pH of 5.0 to 5.8. In the case of the wet wipes composition comprising the antiseptic composition of the present invention does not occur sulfuric acid odor by SDS even in the above pH range, it is excellent in low temperature stability of CPC can be used stably without changing the physical properties when manufacturing wet wipes, low skin irritation Has an excellent effect.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 화장료 조성물에 관한 것이다. According to another embodiment of the present invention, the present invention relates to a cosmetic composition comprising the antiseptic composition.
상기 화장료 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있고, 바람직하게 0.1 중량% 내지 1.5 중량%로 포함할 수 있다. 상기 방부 조성물의 함량이 0.1 중량% 미만인 경우, 항균 및 항진균 효과와 지속성이 떨어지고, 상기 10 중량%를 초과하는 경우 피부 자극이 심하거나 물성 조절이 어려워 화장료 조성물의 물성 안정성이 저하되는 문제가 있다.The cosmetic composition is 0.1% by weight of the antiseptic composition It may be included in 10% by weight, preferably 0.1% to 1.5% by weight. If the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, and when the content of the antiseptic composition is greater than 10% by weight, skin irritation is severe or physical properties are difficult to control, thereby deteriorating physical stability of the cosmetic composition.
상기 화장료 조성물은 제조하고자 하는 화장료 조성물의 제형 또는 물성에 따라 pH 조절제, 보습제, 향료, 계면활성제, 기타 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있고, 바람직하게는 pH 조절제 0.01 중량% 내지 10 중량%, 보습제 0.01 중량% 내지 30 중량%, 향료 0.01 중량% 내지 3.0 중량%, 계면활성제 0.01 중량% 내지 30 중량%, 기타 첨가제 및 정제수를 포함할 수 있다. 상기 범위를 만족하는 화장료 조성물의 경우, 본 발명의 항균 및 항진균 효과가 우수하면서도, 물성의 안정성이 우수한 효과가 있다. The cosmetic composition may further include any one selected from the group consisting of pH adjusters, moisturizers, perfumes, surfactants, other additives, purified water, and combinations thereof, depending on the formulation or physical properties of the cosmetic composition to be prepared, preferably 0.01% to 10% by weight of pH adjuster, 0.01% to 30% by weight of moisturizer, 0.01% to 3.0% by weight of perfume, 0.01% to 30% by weight of surfactant, and other additives and purified water. In the case of the cosmetic composition satisfying the above range, the antibacterial and antifungal effect of the present invention is excellent, but the stability of physical properties is excellent.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 샴푸 조성물에 관한 것이다. According to another embodiment of the present invention, the present invention relates to a shampoo composition comprising the antiseptic composition.
상기 샴푸 조성물은 상기 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있고, 바람직하게 0.1 중량% 내지 1.5 중량%로 포함할 수 있다. 상기 방부 조성물의 함량이 0.1 중량% 미만인 경우, 항균 및 항진균 효과와 지속성이 떨어지고, 상기 10 중량% 초과하는 경우 피부 자극이 심하거나 샴푸 물성 조절이 어려운 문제가 있다.The shampoo composition is 0.1 wt% to the preservative composition 10 It may be included in the weight%, preferably 0.1 to 1.5% by weight. If the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, if the content exceeds 10% by weight of the skin irritation is severe or difficult to control the shampoo properties.
상기 샴푸 조성물은 pH 조절제, 보습제, 향료, 계면활성제, 기타 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. 바람직하게는 pH 조절제 0.01 중량% 내지 10.0 중량%, 보습제 0.01 중량% 내지 30 중량%, 향료 0.01 중량% 내지 3.0 중량%, 계면활성제 0.01 중량% 내지 30 중량%, 기타 첨가제 및 정제수를 포함할 수 있다. 상기 범위를 만족하는 화장료 조성물의 경우, 본 발명의 항균 및 항진균 효과가 우수하면서도, 물성의 안정성이 우수한 효과가 있다.The shampoo composition may further include any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, other additives, purified water and combinations thereof. Preferably, 0.01% to 10.0% by weight of pH adjuster, 0.01% to 30% by weight of moisturizer, 0.01% to 3.0% by weight of perfume, 0.01% to 30% by weight of surfactant, and other additives and purified water may be included. . In the case of the cosmetic composition satisfying the above range, the antibacterial and antifungal effect of the present invention is excellent, but the stability of physical properties is excellent.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 세제용 조성물에 관한 것이다. According to another embodiment of the present invention, the present invention relates to a composition for detergent comprising the antiseptic composition.
상기 세제용 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있고, 바람직하게 0.1 중량% 내지 1.5 중량%로 포함할 수 있다. 상기 방부 조성물의 함량이 0.1 중량% 미만인 경우, 항균 및 항진균 효과 및 지속성이 떨어지고, 상기 10 중량%를 초과하는 경우 피부 자극이 심하거나 물성 조절이 어려운 문제가 있다.The detergent composition may include 0.1 wt% to 10 wt% of the antiseptic composition, preferably 0.1 wt% to 1.5 wt%. When the content of the antiseptic composition is less than 0.1% by weight, the antibacterial and antifungal effects and persistence is lowered, and when the content of the antiseptic composition exceeds 10% by weight, skin irritation is severe or physical property is difficult to control.
상기 세제용 조성물은 pH 조절제, 보습제, 향료, 계면활성제, 소포제, 기타 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. 바람직하게는 pH 조절제 0.01 중량% 내지 10.0 중량%, 보습제 0.01 중량% 내지 30 중량%, 향료 0.01 중량% 내지 3.0 중량%, 계면활성제 0.01 중량% 내지 30 중량%, 소포제 0.01 중량% 내지 1 중량%, 기타 첨가제 및 정제수를 포함할 수 있다. 상기 범위를 만족하는 세제용 조성물의 경우, 본 발명의 항균 및 항진균 효과가 우수하면서도, 물성의 안정성이 우수한 효과가 있다.The detergent composition may further include any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, antifoaming agents, other additives, purified water, and combinations thereof. Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water. In the case of the detergent composition satisfying the above range, while excellent in the antibacterial and antifungal effect of the present invention, there is an effect excellent in the stability of physical properties.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 섬유유연제용 조성물에 관한 것이다. According to another embodiment of the present invention, the present invention relates to a composition for fabric softener comprising the antiseptic composition.
상기 섬유유연제용 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있다. 상기 방부 조성물의 함량이 0.1 중량% 미만인 경우, 항균 및 항진균 효과와 지속성이 떨어지고, 상기 10 중량%를 초과하는 경우 피부 자극이 심하거나 섬유유연제의 물성 조절이 어려운 문제가 있다.The composition for the fabric softener is 0.1% by weight to the antiseptic composition It may comprise 10% by weight. When the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence are inferior, and when the content is greater than 10% by weight, skin irritation is severe or it is difficult to control properties of the fabric softener.
상기 섬유유연제용 조성물은 pH 조절제, 보습제, 향료, 계면활성제, 소포제, 기타 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. 바람직하게는 pH 조절제 0.01 중량% 내지 10.0 중량%, 보습제 0.01 중량% 내지 30 중량%, 향료 0.01 중량% 내지 3.0 중량%, 계면활성제 0.01 중량% 내지 30 중량%, 소포제 0.01 중량% 내지 1 중량%, 기타 첨가제 및 정제수를 포함할 수 있다. 상기 범위를 만족하는 섬유 유연제 조성물의 경우, 본 발명의 항균 및 항진균 효과가 우수하면서도, 물성의 안정성이 우수한 효과가 있다.The fabric softener composition may further include any one selected from the group consisting of pH adjusters, moisturizers, flavoring agents, surfactants, antifoaming agents, other additives, purified water and combinations thereof. Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water. In the case of the fabric softener composition satisfying the above range, the antibacterial and antifungal effect of the present invention is excellent, but the stability of physical properties is excellent.
본 발명의 또 다른 일 구현예에 따르면, 본 발명은 상기 방부 조성물을 포함하는 산업용 세정제 조성물에 관한 것이다. According to another embodiment of the present invention, the present invention relates to an industrial detergent composition comprising the antiseptic composition.
상기 산업용 세정제 조성물은 상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함할 수 있고, 바람직하게 0.1 중량% 내지 5 중량%로 포함할 수 있다. 상기 방부 조성물의 함량이 0.1 중량% 미만인 경우, 항균 및 항진균 효과와 지속성이 떨어지고, 상기 10 중량%를 초과하는 경우 산업용 세정제 조성물의 물성 조절이 어려운 문제가 있다.The industrial detergent composition is 0.1% by weight of the antiseptic composition It may be included in 10% by weight, preferably from 0.1% to 5% by weight. When the content of the antiseptic composition is less than 0.1% by weight, the antimicrobial and antifungal effect and persistence is lowered, and when the content of the antiseptic composition exceeds 10% by weight, it is difficult to control the physical properties of the industrial cleaning composition.
상기 산업용 세정제 조성물은 상기 pH 조절제, 보습제, 향료, 계면활성제, 소포제, 기타 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함할 수 있다. 바람직하게는 pH 조절제 0.01 중량% 내지 10.0 중량%, 보습제 0.01 중량% 내지 30 중량%, 향료 0.01 중량% 내지 3.0 중량%, 계면활성제 0.01 중량% 내지 30 중량%, 소포제 0.01 중량% 내지 1 중량%, 기타 첨가제 및 정제수를 포함할 수 있다. 상기 범위를 만족하는 산업세정용 조성물의 경우, 본 발명의 항균 및 항진균 효과가 우수하면서도, 물성의 안정성이 우수한 효과가 있다.The industrial detergent composition may further include any one selected from the group consisting of the pH adjusting agent, moisturizer, flavoring agent, surfactant, antifoaming agent, other additives, purified water, and combinations thereof. Preferably 0.01 wt% to 10.0 wt% of pH adjuster, 0.01 wt% to 30 wt% of moisturizer, 0.01 wt% to 3.0 wt% of perfume, 0.01 wt% to 30 wt% of surfactant, 0.01 wt% to 1 wt% of antifoaming agent, Other additives and purified water. Industrial cleaning composition satisfying the above range, while excellent in the antibacterial and antifungal effect of the present invention, there is an effect of excellent stability of physical properties.
본 발명의 또 다른 일 구현예에 따라, 본 발명은 상기 방부 조성물을 포함하는 물품을 제공하고, 상기 물품의 일 예로 기저귀, 생리용품, 화장품, 세정제, 산업용 세정제, 살균제 및 위생용품을 포함한다. 상기 위생용품은 일 예로, 구강용 티슈, 구강 청결제, 샴푸, 비누, 샤워젤 등 일 수 있다. According to another embodiment of the present invention, the present invention provides an article comprising the antiseptic composition, and examples of the article include a diaper, a sanitary ware, a cosmetic, a detergent, an industrial cleaner, a disinfectant, and a hygiene product. The hygiene article may be, for example, oral tissue, mouthwash, shampoo, soap, shower gel, and the like.
상기 물품에, 본 발명의 방부 조성물이 물품의 총 중량 대비 0.1 중량% 내지 10 중량%로 포함되는 것이 바람직하다. 상기 물품의 총 중량 대비 방부 조성물이 0.1 중량% 미만이면 항균 및 항진균 효과가 미흡하고, 10 중량%를 초과하는 경우 제품의 물성 변화 및 피부 자극을 유발할 수 있다. Preferably, the article comprises an antiseptic composition of the present invention in an amount of 0.1 wt% to 10 wt% based on the total weight of the article. If the antiseptic composition is less than 0.1% by weight relative to the total weight of the article, the antimicrobial and antifungal effects are insufficient, and when the antiseptic composition is more than 10% by weight, the physical properties of the product and skin irritation may be caused.
본 발명의 방부 조성물을 포함하는 물품은 본 발명의 분야에서 통상적으로 물품을 제조하는 방법에 따라 제조할 수 있고, 일 예로 본 발명의 방부 조성물을 추가의 성분으로 혼합하여 제조하거나, 물품을 제조한 후 마지막 단계에서 제조 물품에 본 발명의 방부 조성물을 처리하는 방법으로 제조할 수 있다. An article comprising the antiseptic composition of the present invention may be prepared according to a method of manufacturing an article in the field of the present invention, for example, prepared by mixing the antiseptic composition of the present invention as an additional component or preparing an article. In the last step, it can be prepared by the method of treating the preservative composition of the present invention in the article of manufacture.
상기 방부 조성물을 물품에 처리하는 방법으로는 통상적으로 사용되는 방법을 모두 사용할 수 있고, 일 예로 방부 조성물을 물품에 스프레이 처리하거나, 방부 조성물에 제조 물품을 함침하거나, 제조 물품 제조공정의 일정한 단계에서 방부 조성물을 투입하여 혼합하는 방법으로 처리할 수 있다. As a method of treating the antiseptic composition to an article, all conventionally used methods may be used. For example, the antiseptic composition may be sprayed onto the article, the antiseptic composition is impregnated with the manufactured article, or at a predetermined stage of the manufactured article manufacturing process. It can process by the method of adding an antiseptic composition and mixing.
물품이 화장품인 경우 제조 물품 제조공정의 일정한 단계에 본 발명의 방부조성물을 투입하고 교반기 등을 통한방법을 이용하여 혼합하는 방법으로 제조할 수 있다.If the article is a cosmetic, it can be prepared by the method of adding the antiseptic composition of the present invention to a certain step of the manufacturing article manufacturing process and mixing using a method such as a stirrer.
물품이 세정제인 경우 액체상태의 세정제 제조의 경우는 제조 물품 제조공정의 일정한 단계에 본 발명의 방부조성물을 투입하고 교반기 등을 통한 방법을 이용하여 혼합하는 방법으로 제조할 수 있고, 고체나 분말상태의 세정제 제조의 경우 제조 물품 제조공정의 일정한 단계에 본 발명의 방부조성물을 투입하고 교반기등을 통한 방법을 이용하여 혼합하고 건조하거나, 건조 후 파쇄하는 방법으로 제조할 수 있다.In case the article is a detergent, in the case of the preparation of a liquid detergent, the antiseptic composition of the present invention may be added to a predetermined step of the manufacturing process of the manufactured article and mixed by using a method such as a stirrer, and may be prepared in a solid or powder state. In the case of the preparation of the detergent, the preservative composition of the present invention may be added to a predetermined step of the manufacturing process of the manufactured article, and mixed by using a method such as a stirrer, dried, or crushed after drying.
물품이 기저귀 및 여성위생용품인 경우 대부분의 경우 섬유형태로 제조되며 제조 물품 제조공정의 일정한 단계에 본 발명의 방부조성물을 투입하고 함침하고 결합시킨 후 건조하는 방법으로 제조할 수 있다.If the article is a diaper and feminine hygiene products in most cases is made in the form of fibers and can be prepared by the method of adding the impregnated composition of the present invention, impregnated, combined and dried in a certain step of the manufacturing article manufacturing process.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily practice the present invention. As those skilled in the art would realize, the described embodiments may be modified in various different ways, all without departing from the spirit or scope of the present invention.
<< 실시예Example > 방부 조성물의 제조 > Preparation of Preservative Composition
적당량의 정제수에 하기 표 1과 같이, 소듐 메타바이설파이트(Sodium Metabisulfite, SDS) 및 염화 세틸피리디늄(Cetylpyridinium chloride, CPC) 각각을 녹이고, 실온에서 혼합하여, 본 발명의 방부 조성물 1kg을 제조하였다. 본 실험에서는 이온교환수지를 사용하여 칼슘 중량을 3ppm 이하로 관리된 정제수를 사용하여 제조하였다.Sodium Metabisulfite (SDS) and Cetylpyridinium chloride (CPC), respectively, were dissolved in an appropriate amount of purified water and mixed at room temperature to prepare 1 kg of the antiseptic composition of the present invention. . In this experiment, using ion-exchange resin was prepared using purified water managed to less than 3ppm calcium weight.
표 1
Sodium Metabisulfite(ppm) Cetylpyridinium chloride(ppm)
비교예 1 1000 0
실시예 1 1000 200
실시예 2 1000 250
실시예 3 1000 500
실시예 4 1000 2500
실시예 5 1000 4000
실시예 6 1000 5000
비교예 2 0 1000
Table 1
Sodium Metabisulfite (ppm) Cetylpyridinium chloride (ppm)
Comparative Example 1 1000 0
Example 1 1000 200
Example 2 1000 250
Example 3 1000 500
Example 4 1000 2500
Example 5 1000 4000
Example 6 1000 5000
Comparative Example 2 0 1000
또한, 적당량의 정제수에 SDS, CPC, 소듐 설파이트(Sodium sulfite) 및 헥실렌 글리콜(Hexylene Glycol) 각각을 하기 표 2와 같은 조성으로 녹이고, 실온에서 혼합하여, 본 발명의 방부 조성물 1kg을 제조하였다. 본 실험에서는 이온교환수지를 사용하여 칼슘 중량을 3ppm 이하로 관리된 정제수를 사용하여 제조하였다.In addition, SDS, CPC, sodium sulfite and hexylene glycol were dissolved in a composition as shown in Table 2 in an appropriate amount of purified water, and mixed at room temperature to prepare 1 kg of the antiseptic composition of the present invention. . In this experiment, using ion-exchange resin was prepared using purified water managed to less than 3ppm calcium weight.
표 2
[중량비] 실시예7 실시예8 실시예9 실시예10
Sodium Metabisulfite 10 10 10 10
Cetylpyridinium chloride 40 40 40 40
Sodium sulfite 0 10 0 5
Hexylene Glycol 0 0 10 5
정제수 80 80 80 80
TABLE 2
[Weight ratio] Example 7 Example 8 Example 9 Example 10
Sodium Metabisulfite 10 10 10 10
Cetylpyridinium chloride 40 40 40 40
Sodium sulfite 0 10 0 5
Hexylene glycol 0 0 10 5
Purified water 80 80 80 80
또한, 적당량의 정제수에 SDS, CPC, 소듐 설파이트(Sodium sulfite, SS), 헥실렌 글리콜(Hexylene Glycol, HG) 및 각종 계면활성제 각각을 하기 표 3과 같은 조성으로 녹이고, 실온에서 혼합하여, 본 발명의 방부 조성물 1kg을 제조하였다. 본 실험에서는 이온교환수지를 사용하여 칼슘 중량을 3ppm 이하로 관리된 정제수를 사용하여 제조하였다.In addition, SDS, CPC, sodium sulfite (SS), hexylene glycol (Hexylene Glycol, HG) and various surfactants were dissolved in an appropriate amount of purified water in the composition shown in Table 3 below, and mixed at room temperature, 1 kg of the antiseptic composition of the invention was prepared. In this experiment, using ion-exchange resin was prepared using purified water managed to less than 3ppm calcium weight.
표 3
[중량비] SDS CPC SS HG 계면활성제, 중량비 정제수
실시예 11 2 8 5 5 소듐라우릴설페이트, 5 75
실시예 12 2 8 5 5 소듐자일렌설포네이트, 5 75
실시예 13 2 8 5 5 암모늄라우레스설페이트, 5 75
실시예 14 2 8 5 5 디소듐라우레스설포석시네이트, 5 75
실시예 15 2 8 5 5 소듐라우로일사코시네이트, 5 75
실시예 16 2 8 5 5 라우레스-7, 5 75
실시예 17 2 8 5 5 라우레스-9, 5 75
실시예 18 2 8 5 5 코코-글루코사이드, 5 75
실시예 19 2 8 5 5 폴리소르베이트 20, 5 75
실시예 20 2 8 5 5 폴리소르베이트 60, 5 75
실시예 21 2 8 5 5 디소듐코코암포디아세테이트, 5 75
실시예 22 2 8 5 5 코카미도프로필 베타인, 5 75
TABLE 3
[Weight ratio] SDS CPC SS HG Surfactant, weight ratio Purified water
Example 11 2 8 5 5 Sodium lauryl sulfate, 5 75
Example 12 2 8 5 5 Sodium xylenesulfonate, 5 75
Example 13 2 8 5 5 Ammonium laureth sulfate, 5 75
Example 14 2 8 5 5 Disodium laureth sulfosuccinate, 5 75
Example 15 2 8 5 5 Sodium lauroyl sarcosinate, 5 75
Example 16 2 8 5 5 Laures-7, 5 75
Example 17 2 8 5 5 Laureth-9, 5 75
Example 18 2 8 5 5 Coco-glucoside, 5 75
Example 19 2 8 5 5 Polysorbate 20, 5 75
Example 20 2 8 5 5 Polysorbate 60, 5 75
Example 21 2 8 5 5 Disodium coco ampodiacetate, 5 75
Example 22 2 8 5 5 Cocamidopropyl betaine, 5 75
<< 제조예Production Example 1> 본 발명의 방부 조성물을 포함하는 물티슈 제조 1> Wet wipes containing the antiseptic composition of the present invention
상기 표 1의 실시예 1 내지 6 및 비교예 1 내지 2와 같이 제조한 방부 조성물을 이용하여 물티슈 조성물을 제조하였다. 표 1의 방부 조성물을 정제수에 첨가하여 교반하고, 부가적으로 향료, 추출물, 보습제를 순서에 상관없이 첨가하여 실온에서 교반하였다. Wet tissue compositions were prepared using the antiseptic compositions prepared in Examples 1 to 6 and Comparative Examples 1 and 2 of Table 1. The antiseptic composition shown in Table 1 was added to purified water and stirred, and additionally, flavors, extracts, and moisturizers were added in any order and stirred at room temperature.
상기 향료로는 시트러스향 0.01 중량%, 마치현 추출물 0.1 중량%, 보습제로서 글리세린을 0.5 중량%를 첨가하였다. 향료, 추출물 및 보습제를 첨가후, pH조절제로서 구연산, 구연산나트륨 및 기타 pH조절제를 0.05 중량% 첨가하고, pH를 4.8~5.8로 버퍼링하여 최종생성물인 물티슈 조성물을 제조하였다.As the fragrance, 0.01% by weight of citrus flavor, 0.1% by weight of extract of Machi, and 0.5% by weight of glycerin as a moisturizing agent were added. After adding the fragrance, extract and moisturizer, 0.05 wt% of citric acid, sodium citrate and other pH adjusting agents were added as a pH adjusting agent, and the final product was prepared by buffering the pH to 4.8 to 5.8.
제조된 물티슈 조성물을 물티슈 제조기계를 통하여 물티슈 원단이 컨버팅 기계에서 지나갈 때 스프레이 장치로 원단에 분사하여 도포하고, 도포된 물티슈 원단을 규격에 맞추어서 재단하여 물티슈를 제조하였다.The wet tissue composition was sprayed onto the fabric using a spray apparatus when the wet tissue fabric passed through the converting machine through the wet tissue manufacturing machine, and the wet tissue fabric was cut to meet the specifications to prepare a wet tissue.
<< 제조예Production Example 2> 본 발명의 방부 조성물을 포함하는  2> containing the antiseptic composition of the present invention 화장료Cosmetics 조성물의 제조 Preparation of the composition
하기 표 4에 기재된 조성으로, 실시예 1 내지 6 및 비교예 1 내지 2의 방부 조성물을 포함하는 화장료 조성물을 제조하였다. To the composition shown in Table 4, to prepare a cosmetic composition comprising the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2.
표 4
No. Trade Name INCI Name 함량(중량%)
1 DC9040 Cyclopentasiloxane(and)Dimethicone Crosspolymer 1
2 SF0005Z Cyclopentasiloxane 10
3 Cegesoft SB 45 Shea Butter 1.5
4 Olive Oil Olea Europaea(Olive) Fruit Oil 0.5
5 Myritol 312 Caprilic/Capric Trigliceride 2
6 Cegesoft C24W Ethylhexyl Palmitate 3
7 Abil EM 90 Cetyl PEG/PPG-10/1 dimethicone 1.2
8 D.I Water Water to 100
9 Niacineamide Niacineamide 5
10 EDTA2Na Disodium EDTA 0.02
11 Keltrol-F Xanthan Gum 0.2
12 Glycerin Glycerin 5
13 1.3 BG 1.3 BG 5
14 Sodium hyaluronate Sodium hyaluronate 0.05
15 방부 조성물 실시예 1-6, 비교예 1-2 1.0
Table 4
No. Trade Name INCI Name Content (% by weight)
One DC9040 Cyclopentasiloxane (and) Dimethicone Crosspolymer One
2 SF0005Z Cyclopentasiloxane 10
3 Cegesoft SB 45 Shea butter 1.5
4 Olive Oil Olea Europaea (Olive) Fruit Oil 0.5
5 Myritol 312 Caprilic / Capric Trigliceride 2
6 Cegesoft C24W Ethylhexyl Palmitate 3
7 Abil EM 90 Cetyl PEG / PPG-10 / 1 dimethicone 1.2
8 DI Water Water to 100
9 Niacineamide Niacineamide 5
10 EDTA2Na Disodium EDTA 0.02
11 Keltrol-F Xanthan Gum 0.2
12 Glycerin Glycerin 5
13 1.3 BG 1.3 BG 5
14 Sodium hyaluronate Sodium hyaluronate 0.05
15 Antiseptic composition Example 1-6, Comparative Example 1-2 1.0
구체적으로, 상기 표 4에 기재된 성분 중, No. 9~11은 2500rpm Disper에서 78℃에서 10분간 교반하고, No. 1~8 역시 78℃에서 교반한 후, 서로 혼합하여 4000rpm에서 Homo mixer로 15 분, 78℃에서 교반을 하였다. 이후 서서히 냉각을 하며 40 ℃ 이하의 온도에서 향료와 실시예에서 제조한 방부 조성물을 균일하게 첨가하여 용해시켜 에멀전을 제조하였다.Specifically, among the components described in Table 4 above, No. 9-11 was stirred for 10 minutes at 78 degreeC in 2500 rpm Disper, and No. After stirring 1 ~ 8 also at 78 ℃, they were mixed with each other for 15 minutes with a Homo mixer at 4000rpm, was stirred at 78 ℃. Thereafter, the mixture was slowly cooled, and the emulsion was prepared by uniformly adding the fragrance and the antiseptic composition prepared in Example at a temperature of 40 ° C. or lower.
<< 제조예Production Example 3> 본 발명의 방부 조성물을 포함하는 샴푸 제조 3> Preparation of shampoo comprising the antiseptic composition of the present invention
하기 표 5에 기재된 조성으로, 실시예 1 내지 6 및 비교예 1 내지 2의 방부 조성물을 포함하는 샴푸를 제조하였다.To the composition shown in Table 5, to prepare a shampoo comprising the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2.
표 5
No. Trade Name INCI Name 함량(중량%)
1 Water Water q.s
2 MICONIUM PQ10 J-3000 폴리쿼터늄-10 0.25
3 EDTA-2NA 디소듐이디티에이 0.10
5 Miconol-C2M 디소듐코코암포디아세테이트 15.00
6 Mitain-CA(S) 코카미도프로필베타인 7.00
7 Miconate-LES 디소듐라우레스설포석시네이트 7.00
8 Plantacare-2000UP 데실글루코사이드 5.00
9 1,3-Butylene Glycol 부틸렌글라이콜 2.00
10 DOE-120 피이지-120메칠글루코오스디올리에이트 0.50
11 CROTHIX-PA-(MH) 피이지-150펜타에리스리틸테트라스테아레이트 0.50
12 Phospholipid-EFA 리놀레아미도프로필피지-디모늄클로라이드포스페이트 1.00
13 Gluadin-WLM BENZ 하이드롤라이즈드밀단백질 0.30
14 D-Panthenol 판테놀 0.20
15 XIAMETER® MEM-1870 EMULSION 디메치콘 1.00
16 Sodium Xylenesulfonate 소듐자일렌설포네이트 0.50
17 Fragrance 향료 1.20
18 Jojoba-Oil 호호바씨 오일 0.50
19 Purac HS-88 Lactic Acid 0.30
20 방부 조성물 실시예 1-6, 비교예 1-2 1.0
Table 5
No. Trade Name INCI Name Content (% by weight)
One Water Water qs
2 MICONIUM PQ10 J-3000 Polyquaternium-10 0.25
3 EDTA-2NA Disodium ID 0.10
5 Miconol-c2m Disodium coco ampodiacetate 15.00
6 Mitain-CA (S) Cocamidopropyl Betaine 7.00
7 Miconate-LES Disodium laureth sulfosuccinate 7.00
8 Plantacare-2000UP Decylglucoside 5.00
9 1,3-Butylene Glycol Butylene Glycol 2.00
10 DOE-120 Fiji-120methylglucose dioleate 0.50
11 CROTHIX-PA- (MH) Fiji-150 pentaerythritol tetrastearate 0.50
12 Phospholipid-EFA Linoleamidopropyl sebum-dimonium chloride phosphate 1.00
13 Gluadin-WLM BENZ Hydrolyzed Wheat Protein 0.30
14 D-Panthenol Panthenol 0.20
15 XIAMETER® MEM-1870 EMULSION Dimethicone 1.00
16 Sodium Xylenesulfonate Sodium xylenesulfonate 0.50
17 Fragrance Spices 1.20
18 Jojoba-oil Jojoba seed oil 0.50
19 Purac HS-88 Lactic acid 0.30
20 Antiseptic composition Example 1-6, Comparative Example 1-2 1.0
구체적으로, 1~3번을 차례로 투입 후 40℃에서 투명해질 때까지 교반 후, 5~8번까지 차례로 투입하여 투명할 때까지 교반하였다. 이후 9~11번을 50℃에서 예 혼합하여, 본 혼합에 투입하고, 서서히 냉각하면서 12번부터 차례대로 투입하였다. pH 5 내지 6으로 버퍼링하여 샴푸를 제조하였다.Specifically, 1 to 3 times were added sequentially and then stirred until it became transparent at 40 ° C., then 5 to 8 times were added sequentially and stirred until it was transparent. Thereafter, Nos. 9 to 11 were premixed at 50 ° C. and added to the main mixture, and were sequentially added from No. 12 while gradually cooling. Shampoos were prepared by buffering to pH 5-6.
<< 제조예4Preparation Example 4 > 본 발명의 방부 조성물을 포함하는 > Containing the antiseptic composition of the present invention 세탁세제Laundry detergent 제조 Produce
하기 표 6에 기재된 조성으로, 실시예 1 내지 6 및 비교예 1 내지 2의 방부 조성물을 포함하는 세탁세제를 제조하였다.To the composition shown in Table 6, to prepare a laundry detergent comprising the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2.
표 6
No. Trade Name INCI Name 함량(%)
1 정제수 WATER to 100
2 LAS linear alkyl benzene sulfonate 12.000
3 DEA Cocamide DEA 4.500
4 SLES Sodium Laureth Sulfate 1.000
5 Glucopon-650 EC Akylpolyglucocide 0.500
6 EDTA-4NA Tetrasodium EDTA 0.100
7 적색 40호 BLUE 1 0.000
8 Citric acid Citric acid 0.010
9 자몽 추출물 Citrus Paradisi (Grapefruit) Fruit Extract 0.010
10 녹차추출물 Camellia Sinensis Leaf Extrac 0.010
11 Fragrance 0.100
12 DB-110A Dimethicone 0.100
13 방부 조성물 실시예 1-6, 비교예 1-2 1.0
Table 6
No. Trade Name INCI Name content(%)
One Purified water WATER to 100
2 LAS linear alkyl benzene sulfonate 12.000
3 DEA Cocamide DEA 4.500
4 SLES Sodium Laureth Sulfate 1.000
5 Glucopon-650 EC Akylpolyglucocide 0.500
6 EDTA-4NA Tetrasodium EDTA 0.100
7 Red 40 BLUE 1 0.000
8 Citric acid Citric acid 0.010
9 Grapefruit extract Citrus Paradisi (Grapefruit) Fruit Extract 0.010
10 Green Tea Extract Camellia Sinensis Leaf Extrac 0.010
11 incense Fragrance 0.100
12 DB-110A Dimethicone 0.100
13 Antiseptic composition Example 1-6, Comparative Example 1-2 1.0
<< 제조예Production Example 5> 본 발명의 방부 조성물을 포함하는  5> comprising the antiseptic composition of the present invention 섬유유연제의Fabric softener 제조 Produce
하기 표 7에 기재된 조성으로, 실시예 1 내지 6 및 비교예 1 내지 2의 방부 조성물을 포함하는 섬유유연제를 제조하였다.To the composition shown in Table 7 below, fabric softeners containing the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2 were prepared.
표 7
No. Trade Name INCI Name 함량(%)
1 정제수 WATER to 100
2 EDTA-4NA Tetrasodium EDTA 0.100
3 Hisofter MEQ-80 Dihydrogenated Palmoyl Hydroxyethylmonium Methosulfate 3.0000
4 HONEOL LAE-15 Laureth-15 0.7000
5 MEG Ethylene Glycol 3.0000
6 Citric acid Citric acid 0.020
7 NaCl NaCl 0.1000
8 Fragrance 0.5000
9 DB-110A Dimethicone 0.1000
10 방부 조성물 실시예 1-6, 비교예 1-2 1.0
TABLE 7
No. Trade Name INCI Name content(%)
One Purified water WATER to 100
2 EDTA-4NA Tetrasodium EDTA 0.100
3 Hisofter MEQ-80 Dihydrogenated Palmoyl Hydroxyethylmonium Methosulfate 3.0000
4 HONEOL LAE-15 Laureth-15 0.7000
5 MEG Ethylene Glycol 3.0000
6 Citric acid Citric acid 0.020
7 NaCl NaCl 0.1000
8 incense Fragrance 0.5000
9 DB-110A Dimethicone 0.1000
10 Antiseptic composition Example 1-6, Comparative Example 1-2 1.0
<< 제조예Production Example 6> 본 발명의 방부 조성물을 포함하는 산업용 기름때 제거제의 제조 6> Preparation of industrial degreaser comprising the antiseptic composition of the present invention
하기 표 8에 기재된 조성으로, 실시예 1 내지 6 및 비교예 1 내지 2의 방부 조성물을 포함하는 산업용 기름때 제거제를 제조하였다. To the composition shown in Table 8, was prepared an industrial degreaser comprising the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2.
표 8
No. Trade Name 함량(%)
1 Water To 100
2 Tetrasodium EDTA, 38% 10
3 Sodium metasilicate anhydrous 5
4 PEG-16 tallow ethyl ammonium ethosulfate 3
5 Alcohol Ethoxylate 4
6 방부 조성물, 실시예 1-6, 비교예 1-2 1.0
Table 8
No. Trade Name content(%)
One Water To 100
2 Tetrasodium EDTA, 38% 10
3 Sodium metasilicate anhydrous 5
4 PEG-16 tallow ethyl ammonium ethosulfate 3
5 Alcohol Ethoxylate 4
6 Antiseptic composition, Example 1-6, Comparative Example 1-2 1.0
<< 실험예Experimental Example 1> 본 발명의 방부 조성물의 항균 및 항진균 효과 확인 1> Confirm the antibacterial and antifungal effect of the antiseptic composition of the present invention
본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 Shaking Flask Method을 통해 세균인 대장균(Escherichia coli), 황색포도상구균(Staphylococcus aureus) 및 녹농균(Pseudomonas aeruginosa) 의 경우 영양배지(Nutrient Broth) 100mL, 진균인 흑곰팡이균(Aspergillus niger), 칸디다 알비칸스(candida albicans)의 경우, 포테이토 덱스트로스 브로스(Potato dextrose Broth) 100mL 에서 배양된 균주를 백금으로 취하여 접종하였다. 접종된 배지는 회전항온 배양기(Shaking incubator)로 30℃에서 24 시간 배양했다. 방부제를 첨가하지 않은 0.9% NaCl 용액의 수용액에 실시예 1 내지 6 및 비교예 1 내지 2의 의 방부 조성물 각각을 1.00 중량%로 넣고, 대조군(Control)에는 동량의 정제수를 넣어 각 100ml 가 들어있는 Tube에 106 CFU/ml의 대장균(Escherichia coli), 106 CFU/ml의 황색포도상구균(Staphylococcus aureus), 106 CFU/ml의 녹농균(Pseudomonas aeruginosa), 105 CFU/ml의 흑곰팡이균(Aspergillus niger)과 칸디다 알비칸스(candida albicans)를 각각 접종하였다. 그 후, 각각의 용액에서 1mL를 취하여 0.9% NaCl 용액 0.9ml를 혼합한 후 다시 1ml를 취하여 Spreading 도말법으로 petri-dish 에 3중복으로 적가하였다. 대장균(Escherichia coli) 및 황색포도상구균(Staphylococcus aureus), 녹농균(Pseudomonas aeruginosa)은 35 ℃ 항온 배양기에서 2일간, 흑곰팡이균(Aspergillus niger), 칸디다 알비칸스(candida albicans)는 25 ℃ 항온 배양기에서 3일 정도 배양한 후 군락의 수를 계수한 후 희석배수를 곱하여 1mL 당 균수로 하였고, 그 결과는 하기 표 9에 나타내었다. As an antimicrobial and antifungal test evaluation method of the preservative composition of the present invention, Escherichia coli ( Esherichia) which is a bacterium through Shaking Flask Method coli ), Staphylococcus aureus and Pseudomonas aeruginosa , 100 mL of nutrient broth, Aspergillus niger , In the case of candida albicans , strains incubated in 100 mL of Potato dextrose Broth were inoculated with platinum. The inoculated medium was incubated at 30 ° C. for 24 hours in a shaking incubator. 1.00% by weight of each of the antiseptic compositions of Examples 1 to 6 and Comparative Examples 1 and 2 were added to an aqueous solution of 0.9% NaCl solution without preservatives, and the same amount of purified water was added to the control, which contained 100 ml of each. 10 6 CFU / ml Escherichia in Tube coli ), 10 6 CFU / ml Staphylococcus aureus , 10 6 CFU / ml Pseudomonas aeruginosa, 10 5 CFU / ml fungi ( Aspergillus niger ) and Candida albicans (candida albicans ) Were each inoculated. Thereafter, 1 mL of each solution was taken, 0.9 mL of 0.9% NaCl solution was mixed, 1 mL was further added, and the mixture was added dropwise to petri-dish in three replicates by spreading smearing. Escherichia coli coli ), Staphylococcus aureus , Pseudomonas aeruginosa ) was incubated for 2 days at 35 ℃ incubator, Aspergillus niger and candida albicans incubated for 3 days at 25 ℃ incubator, counting the number of colonies and multiply by dilution factor 1mL The number of sugar bacteria was used, and the results are shown in Table 9 below.
표 9
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
3일차 대장균 1.3 x 106 4 1 0 0 0 0 0 0 1
황색포도상구균 1.04 x 106 4 1 0 0 0 0 0 0 1
녹농균 3.4 x 106 4 1 0 0 0 0 0 0 1
칸디다 알비칸스 1.48 x 105 4 2 0 0 0 0 0 0 2
흑곰팡이균 1.9 x 105 4 2 0 0 0 0 0 0 1
7일차 대장균 1.3 x 106 4 0 0 0 0 0 0 0 1
황색포도상구균 1.04 x 106 4 0 0 0 0 0 0 0 1
녹농균 3.4 x 106 4 0 0 0 0 0 0 0 1
칸디다 알비칸스 1.48 x 105 4 2 0 0 0 0 0 0 3
흑곰팡이균 1.9 x 105 4 2 0 0 0 0 0 0 1
Table 9
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 3 Escherichia coli 1.3 x 10 6 4 One 0 0 0 0 0 0 One
Staphylococcus aureus 1.04 x 10 6 4 One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 3.4 x 10 6 4 One 0 0 0 0 0 0 One
Candida albicans 1.48 x 10 5 4 2 0 0 0 0 0 0 2
Black fungus 1.9 x 10 5 4 2 0 0 0 0 0 0 One
Day 7 Escherichia coli 1.3 x 10 6 4 0 0 0 0 0 0 0 One
Staphylococcus aureus 1.04 x 10 6 4 0 0 0 0 0 0 0 One
Pseudomonas aeruginosa 3.4 x 10 6 4 0 0 0 0 0 0 0 One
Candida albicans 1.48 x 10 5 4 2 0 0 0 0 0 0 3
Black fungus 1.9 x 10 5 4 2 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 8에서 확인된 바와 같이, 소듐메타바이설파이트와 염화 세틸피리디늄을 혼합하여 사용하는 본 발명의 방부 조성물(실시예 1 내지 6)의 경우 SDS 또는 CPC를 단독으로 사용 하는 방부 조성물보다 우수한 항균 및 항진균 작용 효과가 있고, 특히 실시예 1 내지 6의 방부 조성물의 경우 다양한 균주 모두에서 99.9% 이상의 우수한 항균 및 항진균 효과가 있음을 확인하였다. As confirmed in Table 8, in the case of the antiseptic composition of the present invention (Examples 1 to 6) using a mixture of sodium metabisulfite and cetylpyridinium chloride is superior to the antiseptic composition using SDS or CPC alone The antimicrobial and antifungal effect has an effect, and especially in the case of the antiseptic composition of Examples 1 to 6 it was confirmed that there is an excellent antimicrobial and antifungal effect of at least 99.9% in various strains.
<< 실험예Experimental Example 2> 본 발명의 방부 조성물을 포함하는 물티슈의 효과 확인 2> Confirm the effect of the wet tissue containing the antiseptic composition of the present invention
제조예 1에서 제조한 물티슈의 항균 효과를 실험하였으며, 그 결과를 표 10에 나타내었다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 1에 따라 제조한 물티슈 조성물을 이용하여, 물티슈를 제조하였다.The antimicrobial effect of the wet tissue prepared in Preparation Example 1 was tested, and the results are shown in Table 10. As a control, a wet tissue was prepared using the wet tissue composition prepared according to Preparation Example 1 by adding the same amount of purified water instead of the antiseptic composition of the present invention.
표 10
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 2.5 x 106 3 2 2 2 2 1 0 0 2
황색포도상구균 1.5 x 106 4 2 2 2 2 1 0 0 2
녹농균 3.1 x 106 3 2 2 2 2 1 0 0 3
칸디다 알비칸스 1.4 x 105 4 1 1 1 1 1 0 0 2
흑곰팡이균 1.9 x 105 4 2 2 1 1 1 1 0 3
3일차 대장균 2.5 x 106 4 2 0 0 0 0 0 0 2
황색포도상구균 1.5 x 106 3 1 0 0 0 0 0 0 1
녹농균 3.1 x 106 3 1 0 0 0 0 0 0 1
칸디다 알비칸스 1.4 x 105 4 1 0 0 0 0 0 0 2
흑곰팡이균 1.9 x 105 4 2 0 0 0 0 0 0 1
7일차 대장균 2.5 x 106 4 1 0 0 0 0 0 0 1
황색포도상구균 1.5 x 106 4 0 0 0 0 0 0 0 0
녹농균 3.1 x 106 4 0 0 0 0 0 0 0 0
칸디다 알비칸스 1.4 x 105 4 0 0 0 0 0 0 0 3
흑곰팡이균 1.9 x 105 4 3 0 0 0 0 0 0 1
Table 10
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 2.5 x 10 6 3 2 2 2 2 One 0 0 2
Staphylococcus aureus 1.5 x 10 6 4 2 2 2 2 One 0 0 2
Pseudomonas aeruginosa 3.1 x 10 6 3 2 2 2 2 One 0 0 3
Candida albicans 1.4 x 10 5 4 One One One One One 0 0 2
Black fungus 1.9 x 10 5 4 2 2 One One One One 0 3
Day 3 Escherichia coli 2.5 x 10 6 4 2 0 0 0 0 0 0 2
Staphylococcus aureus 1.5 x 10 6 3 One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 3.1 x 10 6 3 One 0 0 0 0 0 0 One
Candida albicans 1.4 x 10 5 4 One 0 0 0 0 0 0 2
Black fungus 1.9 x 10 5 4 2 0 0 0 0 0 0 One
Day 7 Escherichia coli 2.5 x 10 6 4 One 0 0 0 0 0 0 One
Staphylococcus aureus 1.5 x 10 6 4 0 0 0 0 0 0 0 0
Pseudomonas aeruginosa 3.1 x 10 6 4 0 0 0 0 0 0 0 0
Candida albicans 1.4 x 10 5 4 0 0 0 0 0 0 0 3
Black fungus 1.9 x 10 5 4 3 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 10 결과와 같이, 소듐메타바이설파이트와 염화 세틸피리디늄을 혼합하여 사용하는 본 발명의 방부 조성물(실시예 1 내지 6)의 경우 SDS 또는 CPC를 단독으로 사용 하는 방부 조성물보다 우수한 항균 및 항진균 작용 효과가 있고, 특히 실시예 1 내지 6의 방부 조성물의 경우 3일차내에 다양한 균주 모두에서 99.9% 이상의 우수한 항균 및 항진균 효과가 있음을 확인 하였다. 특히, 실시예 5 내지 6에서는 2일차에 다양한 균주 모두에서 99.9% 이상의 우수한 항균 및 항진균 효과가 있음을 확인 하였다. As shown in Table 10, in the case of the antiseptic composition (Examples 1 to 6) of the present invention using sodium metabisulfite and cetylpyridinium chloride in combination, antibacterial and antiseptic properties are superior to those of SDS or CPC alone. There was an antifungal effect, in particular, in the case of the antiseptic composition of Examples 1 to 6 it was confirmed that there are excellent antibacterial and antifungal effect of at least 99.9% in all the various strains within 3 days. In particular, in Examples 5 to 6 it was confirmed that the excellent antibacterial and antifungal effect of at least 99.9% in all the various strains on the second day.
<< 실험예Experimental Example 3> 본 발명의 방부 조성물을 포함하는  3> containing the antiseptic composition of the present invention 화장료Cosmetics 조성물의 효과 확인 Confirm the effect of the composition
제조예 2에서 제조한 화장료 조성물(emulsion)의 항균 및 항진균 효과를 다음과 같은 방법으로 확인하였다. 본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 ASTM D2574 법을 통해 목적물인 화장료 조성물 에멀젼(emulsion)에 104 CFU/ml의 대장균(Escherichia coli), 104 CFU/ml의 황색포도상구균(Staphylococcus aureus), 104 CFU/ml의 녹농균(Pseudomonas aeroginosa)을 혼합하여 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였으며, 105 CFU/ml의 칸디다 알비칸스(candida albicans)와 흑곰팡이균(Aspergillus niger)도 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 2에 따라 제조하였다. 상기 항균 및 항진균 효과의 결과는 표 11에 나타내었다.The antimicrobial and antifungal effects of the cosmetic composition (emulsion) prepared in Preparation Example 2 were confirmed by the following method. With the present invention antibacterial and antifungal capacity test Evaluation of antiseptic compositions of the E. coli 10 4 CFU / ml to the target product, a cosmetic composition emulsion (emulsion) with the ASTM D2574 method (Escherichia coli ), 10 4 CFU / ml Staphylococcus aureus , 10 4 CFU / ml Pseudomonas aeroginosa ) were mixed and streaking, and the results were observed after incubation at room temperature for 3 days and 7 days, and streaking candida albicans and Aspergillus niger at 10 5 CFU / ml. The results were observed after incubation at room temperature for the initial, 3 days and 7 days. A control was prepared according to Preparation Example 2 by adding the same amount of purified water instead of the antiseptic composition of the present invention. The results of the antimicrobial and antifungal effects are shown in Table 11.
표 11
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 2.8 x 106 3 1 2 1 1 1 0 0 2
황색포도상구균 1.6 x 106 4 1 1 1 1 1 0 0 2
녹농균 2.1 x 106 3 1 1 1 1 1 0 0 3
칸디다 알비칸스 1.6 x 105 4 1 1 1 1 1 0 0 2
흑곰팡이균 1.4 x 105 4 2 1 1 1 1 0 0 4
3일차 대장균 2.8 x 106 4 3 0 0 0 0 0 0 2
황색포도상구균 1.6 x 106 4 2 0 0 0 0 0 0 2
녹농균 2.1 x 106 4 2 0 0 0 0 0 0 2
칸디다 알비칸스 1.6 x 105 4 2 0 0 0 0 0 0 3
흑곰팡이균 1.4 x 105 4 3 0 0 0 0 0 0 2
7일차 대장균 2.8 x 106 4 3 0 0 0 0 0 0 1
황색포도상구균 1.6 x 106 4 2 0 0 0 0 0 0 2
녹농균 2.1 x 106 4 3 0 0 0 0 0 0 1
칸디다 알비칸스 1.6 x 105 4 3 0 0 0 0 0 0 3
흑곰팡이균 1.4 x 105 4 2 0 0 0 0 0 0 2
Table 11
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 2.8 x 10 6 3 One 2 One One One 0 0 2
Staphylococcus aureus 1.6 x 10 6 4 One One One One One 0 0 2
Pseudomonas aeruginosa 2.1 x 10 6 3 One One One One One 0 0 3
Candida albicans 1.6 x 10 5 4 One One One One One 0 0 2
Black fungus 1.4 x 10 5 4 2 One One One One 0 0 4
Day 3 Escherichia coli 2.8 x 10 6 4 3 0 0 0 0 0 0 2
Staphylococcus aureus 1.6 x 10 6 4 2 0 0 0 0 0 0 2
Pseudomonas aeruginosa 2.1 x 10 6 4 2 0 0 0 0 0 0 2
Candida albicans 1.6 x 10 5 4 2 0 0 0 0 0 0 3
Black fungus 1.4 x 10 5 4 3 0 0 0 0 0 0 2
Day 7 Escherichia coli 2.8 x 10 6 4 3 0 0 0 0 0 0 One
Staphylococcus aureus 1.6 x 10 6 4 2 0 0 0 0 0 0 2
Pseudomonas aeruginosa 2.1 x 10 6 4 3 0 0 0 0 0 0 One
Candida albicans 1.6 x 10 5 4 3 0 0 0 0 0 0 3
Black fungus 1.4 x 10 5 4 2 0 0 0 0 0 0 2
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 11 결과에서와 같이, 발명의 방부 조성물 실시예 1 내지 6은 3일차에서 모든 세균, 진균류가 사멸율이 99.9%이상으로 우수하였으나, 비교예 1 및 2의 방부 조성물을 포함하는 화장료 조성물에서는 세균 및 진균류에 대한 항균력이 미흡하여 7일차에서도 완전히 사멸이 되지 않음을 확인 하였다. 또한 염화 세틸피리디늄의 함량이 상대적으로 많은 비교예 1에서 항균 및 항진균력이 상대적으로 더 약한 것을 확인 하였다. 따라서, 본 발명의 방부 조성물의 경우, 그 SDS와 CPC를 단순히 혼합하여 사용하는 것이 아니라, 그 중량비에 있어서도 항균 및 항진균력 향상 영향을 주는 것임을 확인 하였다. 특히 실시예 5 내지 6에서는 2일차에서 항진균이 사멸하였다. As shown in the results of Table 11, Examples 1 to 6 of the antiseptic composition of the invention was excellent in the killing rate of more than 99.9% of all bacteria, fungi in the third day, in the cosmetic composition comprising the antiseptic compositions of Comparative Examples 1 and 2 Insufficient antibacterial activity against bacteria and fungi was confirmed to be not completely killed even on day 7. In addition, in Comparative Example 1, where the content of cetylpyridinium chloride is relatively high, it was confirmed that the antibacterial and antifungal activity was relatively weaker. Therefore, in the case of the antiseptic composition of the present invention, it was confirmed that the SDS and CPC are not simply mixed, but also have an antibacterial and antifungal effect improvement in the weight ratio. In particular, in Examples 5 to 6 antifungal was killed on the second day.
<< 실험예Experimental Example 4> 본 발명의 방부 조성물을 포함하는 샴푸의 효과 확인 4> Confirmation of the effect of the shampoo containing the antiseptic composition of the present invention
제조예 3에서 제조한 샴푸의 항균 및 항진균 효과를 다음과 같은 방법으로 실험하였다. 본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 ASTM D2574 법을 통해 목적물인 샴푸에 104 CFU/ml의 대장균(Escherichia coli), 10 4CFU/ml의 황색포도상구균(Staphylococcus aureus), 104 CFU/ml의 녹농균(Pseudomonas aeroginosa)을 혼합하여 streaking 하고, 초기, 1일, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였으며, 항진균 105 CFU/ml의 칸디다 알비칸스(candida albicans)와 흑곰팡이균(Aspergillus niger)도 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 3에 따라 제조하였다. 시험 결과는 하기 표 12에 나타내었다. Antimicrobial and antifungal effects of the shampoo prepared in Preparation Example 3 were tested in the following manner. As an antimicrobial and antifungal test evaluation method of the antiseptic composition of the present invention, Escherichia coli of 10 4 CFU / ml in a shampoo as a target through ASTM D2574 method coli ), 10 4 CFU / ml Staphylococcus aureus , 10 4 CFU / ml Pseudomonas aeroginosa , streaking and mixed incubation at room temperature for 1, 3, 7 days The antifungal 10 5 CFU / ml Candida albicans and Black fungus Aspergillus niger were also streaking, and the results were observed after incubation at room temperature for 3 days and 7 days. A control (control) was prepared according to Preparation Example 3 by adding the same amount of purified water instead of the preservative composition of the present invention. The test results are shown in Table 12 below.
표 12
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 2.8 x 106 3 1 0 0 0 1 1 1 2
황색포도상구균 1.8 x 106 4 1 0 0 0 1 1 1 1
녹농균 2.9 x 106 4 2 0 0 0 1 1 1 1
칸디다 알비칸스 1.4 x 105 4 3 0 0 1 1 1 1 3
흑곰팡이균 1.9 x 105 4 2 0 0 1 1 1 1 1
3일차 대장균 2.8 x 106 4 3 0 0 0 0 0 0 1
황색포도상구균 1.8 x 106 4 2 0 0 0 0 0 0 1
녹농균 2.9 x 106 4 2 0 0 0 0 0 0 0
칸디다 알비칸스 1.4 x 105 4 2 0 0 0 0 0 0 3
흑곰팡이균 1.9 x 105 4 3 0 0 0 0 0 0 1
7일차 대장균 2.8 x 106 3 3 0 0 0 0 0 0 2
황색포도상구균 1.8 x 106 4 2 0 0 0 0 0 0 1
녹농균 2.9 x 106 4 3 0 0 0 0 0 0 1
칸디다 알비칸스 1.4 x 105 4 3 0 0 0 0 0 0 3
흑곰팡이균 1.9 x 105 4 2 0 0 0 0 0 0 1
Table 12
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 2.8 x 10 6 3 One 0 0 0 One One One 2
Staphylococcus aureus 1.8 x 10 6 4 One 0 0 0 One One One One
Pseudomonas aeruginosa 2.9 x 10 6 4 2 0 0 0 One One One One
Candida albicans 1.4 x 10 5 4 3 0 0 One One One One 3
Black fungus 1.9 x 10 5 4 2 0 0 One One One One One
Day 3 Escherichia coli 2.8 x 10 6 4 3 0 0 0 0 0 0 One
Staphylococcus aureus 1.8 x 10 6 4 2 0 0 0 0 0 0 One
Pseudomonas aeruginosa 2.9 x 10 6 4 2 0 0 0 0 0 0 0
Candida albicans 1.4 x 10 5 4 2 0 0 0 0 0 0 3
Black fungus 1.9 x 10 5 4 3 0 0 0 0 0 0 One
Day 7 Escherichia coli 2.8 x 10 6 3 3 0 0 0 0 0 0 2
Staphylococcus aureus 1.8 x 10 6 4 2 0 0 0 0 0 0 One
Pseudomonas aeruginosa 2.9 x 10 6 4 3 0 0 0 0 0 0 One
Candida albicans 1.4 x 10 5 4 3 0 0 0 0 0 0 3
Black fungus 1.9 x 10 5 4 2 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 12에 나타낸 결과와 같이, 실시예 1 내지 6의 방부 조성물을 포함하는 샹푸의 경우, 3일차에서 모든 세균, 진균류가 사멸율이 99.9%이상으로 우수하였으나, 비교예 1 및 비교예 2의 방부 조성물을 포함하는 샴푸 조성물에서는 세균, 진균류에 대한 항균력이 미흡하여 7일차에서도 세균 및 진균을 완전히 사멸시키지 못하였다. 따라서 샴푸에서도, 본 발명의 SDS와 CPC를 특정 비율로 혼합하여 사용하는 경우, 각각 한가지 성분만 사용하는 경우보다 더욱 우수한 항균 및 항진균 효과를 갖는 방부 조성물을 제조할 수 있음을 확인하였다. 특히 실시예 1 내지 2에서는 2일차에서 항진균이 사멸하는 것을 확인하였다.As shown in Table 12, in the case of Xiangpu comprising the antiseptic compositions of Examples 1 to 6, all bacteria and fungi were excellent in killing rate of 99.9% or more on Day 3, but of Comparative Example 1 and Comparative Example 2 In the shampoo composition including the antiseptic composition, the antimicrobial activity against bacteria and fungi was insufficient, so that the bacteria and fungi were not completely killed even on the 7th day. Therefore, even in the shampoo, it was confirmed that when using a mixture of SDS and CPC of the present invention in a specific ratio, an antiseptic composition having better antibacterial and antifungal effects than when using only one component each. In particular, in Examples 1 to 2 it was confirmed that the antifungal kill on the second day.
<< 실험예Experimental Example 5> 본 발명의 방부 조성물을 포함하는 세탁 세제의 효과 확인 5> Confirm the effect of the laundry detergent containing the antiseptic composition of the present invention
제조예 4에서 제조한 세탁세제의 항균 및 항진균 효과를 다음과 같은 방법으로 확인하였다. 본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 ASTM D2574 법을 통해 목적물인 세제에 106 CFU/ml의 대장균(Escherichia coli), 106 CFU/ml의 황색포도상구균(Staphylococcus aureus), 106 CFU/ml의 녹농균(Pseudomonas aeroginosa)을 혼합하여 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였으며, 105 CFU/ml의 칸디다 알비칸스(candida albicans)와 흑곰팡이균(Aspergillus niger)도 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 4에 따라 제조하였고, 시험 결과는 그 결과는 표 13에 나타내었다. The antimicrobial and antifungal effect of the laundry detergent prepared in Preparation Example 4 was confirmed by the following method. As an antimicrobial and antifungal test evaluation method of the antiseptic composition of the present invention, Escherichia coli of 10 6 CFU / ml in a detergent as a target through ASTM D2574 method coli ), 10 6 CFU / ml Staphylococcus aureus and 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, and the results were observed after incubation at room temperature for 3 days and 7 days. In addition, streaking candida albicans and Aspergillus niger at 10 5 CFU / ml, and the results were observed after incubation at room temperature for 3 days and 7 days. A control was prepared according to Preparation Example 4 by adding the same amount of purified water instead of the preservative composition of the present invention, the test results are shown in Table 13.
표 13
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 3.3 x 106 2 1 0 0 0 0 0 1 2
황색포도상구균 2.8 x 106 3 1 0 0 0 0 0 0 1
녹농균 2.1 x 106 3 2 0 0 0 0 0 0 1
칸디다 알비칸스 2.4 x 105 3 3 0 0 1 0 1 1 3
흑곰팡이균 3.2 x 105 4 2 0 0 1 1 1 1 1
3일차 대장균 3.3 x 106 4 1 0 0 0 0 0 0 1
황색포도상구균 2.8 x 106 4 0 0 0 0 0 0 0 1
녹농균 2.1 x 106 4 0 0 0 0 0 0 0 0
칸디다 알비칸스 2.4 x 105 4 0 0 0 0 0 0 0 3
흑곰팡이균 3.2 x 105 4 3 0 0 0 0 0 0 1
7일차 대장균 3.3 x 106 2 3 0 0 0 0 0 0 2
황색포도상구균 2.8 x 106 3 0 0 0 0 0 0 0 1
녹농균 2.1 x 106 3 0 0 0 0 0 0 0 1
칸디다 알비칸스 2.4 x 105 3 1 0 0 0 0 0 0 3
흑곰팡이균 3.2 x 105 2 3 0 0 0 0 0 0 1
Table 13
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 3.3 x 10 6 2 One 0 0 0 0 0 One 2
Staphylococcus aureus 2.8 x 10 6 3 One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 2.1 x 10 6 3 2 0 0 0 0 0 0 One
Candida albicans 2.4 x 10 5 3 3 0 0 One 0 One One 3
Black fungus 3.2 x 10 5 4 2 0 0 One One One One One
Day 3 Escherichia coli 3.3 x 10 6 4 One 0 0 0 0 0 0 One
Staphylococcus aureus 2.8 x 10 6 4 0 0 0 0 0 0 0 One
Pseudomonas aeruginosa 2.1 x 10 6 4 0 0 0 0 0 0 0 0
Candida albicans 2.4 x 10 5 4 0 0 0 0 0 0 0 3
Black fungus 3.2 x 10 5 4 3 0 0 0 0 0 0 One
Day 7 Escherichia coli 3.3 x 10 6 2 3 0 0 0 0 0 0 2
Staphylococcus aureus 2.8 x 10 6 3 0 0 0 0 0 0 0 One
Pseudomonas aeruginosa 2.1 x 10 6 3 0 0 0 0 0 0 0 One
Candida albicans 2.4 x 10 5 3 One 0 0 0 0 0 0 3
Black fungus 3.2 x 10 5 2 3 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 13에 나타낸 바와 같이, 본 발명의 실시예 1 내지 6의 방부 조성물을 포함하는 세탁세제의 경우, 3일차에서 모든 세균, 진균류가 사멸율이 99.9%이상으로 우수하였으나, 비교예 1 내지 2의 세탁세제 조성물에서는 세균, 진균류에 대한 항균력이 미흡하여 7일차에서도 완전히 사멸이 되지 않았다. 따라서, 세탁세제에서도 본 발명의 SDS와 CPC를 특정 비율로 혼합하여 사용하는 경우, 각각 한가지 성분만 사용하는 경우보다 더욱 우수한 항균 및 항진균 효과를 갖는 방부 조성물을 제조할 수 있음을 확인 하였다. 특히 실시예 1 내지 2에서는 2일차에서도 진균이 모두 사멸하는 것을 확인 하였다. As shown in Table 13, in the laundry detergent containing the antiseptic compositions of Examples 1 to 6 of the present invention, all bacteria and fungi were killed at 99.9% or more on the third day, but Comparative Examples 1 to 2 In the laundry detergent composition of the bacteria and fungi lacking antimicrobial activity was not completely killed even on day 7. Therefore, it was confirmed that even when used in a laundry detergent mixed with the SDS and CPC of the present invention at a specific ratio, it was possible to prepare an antiseptic composition having better antibacterial and antifungal effects than when only one component was used. In particular, Examples 1 to 2 confirmed that all fungi were killed even on the second day.
<< 실험예Experimental Example 6> 본 발명의 방부 조성물을 포함하는 섬유  6> fiber comprising the antiseptic composition of the present invention 유연제의Softener 효과 확인 Check the effect
제조예 5에서 제조한 섬유 유연제의 항균 및 항진균 효과를 다음과 같은 방법으로 실험하였다. 본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 ASTM D2574 법을 통해 목적물인 세제에 106 CFU/ml의 대장균(Escherichia coli), 106 CFU/ml의 황색포도상구균(Staphylococcus aureus), 106 CFU/ml의 녹농균(Pseudomonas aeroginosa)을 혼합하여 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였으며, 105 CFU/ml의 칸디다 알비칸스(candida albicans)와 흑곰팡이균(Aspergillus niger)도 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 5에 따라 제조하였고, 상기 시험 결과는 표 14에 나타내었다.The antimicrobial and antifungal effects of the fabric softener prepared in Preparation Example 5 were tested in the following manner. As an antimicrobial and antifungal test evaluation method of the antiseptic composition of the present invention, Escherichia coli of 10 6 CFU / ml in a detergent as a target through ASTM D2574 method coli ), 10 6 CFU / ml Staphylococcus aureus and 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, and the results were observed after incubation at room temperature for 3 days and 7 days. In addition, streaking candida albicans and Aspergillus niger at 10 5 CFU / ml, and the results were observed after incubation at room temperature for 3 days and 7 days. A control was prepared according to Preparation Example 5 by adding the same amount of purified water instead of the preservative composition of the present invention, the test results are shown in Table 14.
표 14
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 2.5 x 106 2 2 0 0 0 0 0 1 2
황색포도상구균 2.1x 106 2 2 0 0 0 0 0 0 2
녹농균 4.2 x 106 2 2 0 0 0 0 0 0 2
칸디다 알비칸스 1.9 x 105 2 1 0 0 1 1 1 1 3
흑곰팡이균 3.5 x 105 4 2 0 0 1 1 1 1 1
3일차 대장균 2.5 x 106 2 2 0 0 0 0 0 0 2
황색포도상구균 2.1x 106 1 1 0 0 0 0 0 0 1
녹농균 4.2 x 106 1 1 0 0 0 0 0 0 1
칸디다 알비칸스 1.9 x 105 2 2 0 0 0 0 0 0 2
흑곰팡이균 3.5 x 105 1 1 0 0 0 0 0 0 1
7일차 대장균 2.5 x 106 1 1 0 0 0 0 0 0 1
황색포도상구균 2.1x 106 1 1 0 0 0 0 0 0 1
녹농균 4.2 x 106 2 2 0 0 0 0 0 0 2
칸디다 알비칸스 1.9 x 105 1 1 0 0 0 0 0 0 1
흑곰팡이균 3.5 x 105 1 1 0 0 0 0 0 0 1
Table 14
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 2.5 x 10 6 2 2 0 0 0 0 0 One 2
Staphylococcus aureus 2.1 x 10 6 2 2 0 0 0 0 0 0 2
Pseudomonas aeruginosa 4.2 x 10 6 2 2 0 0 0 0 0 0 2
Candida albicans 1.9 x 10 5 2 One 0 0 One One One One 3
Black fungus 3.5 x 10 5 4 2 0 0 One One One One One
Day 3 Escherichia coli 2.5 x 10 6 2 2 0 0 0 0 0 0 2
Staphylococcus aureus 2.1 x 10 6 One One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 4.2 x 10 6 One One 0 0 0 0 0 0 One
Candida albicans 1.9 x 10 5 2 2 0 0 0 0 0 0 2
Black fungus 3.5 x 10 5 One One 0 0 0 0 0 0 One
Day 7 Escherichia coli 2.5 x 10 6 One One 0 0 0 0 0 0 One
Staphylococcus aureus 2.1 x 10 6 One One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 4.2 x 10 6 2 2 0 0 0 0 0 0 2
Candida albicans 1.9 x 10 5 One One 0 0 0 0 0 0 One
Black fungus 3.5 x 10 5 One One 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 14에 나타낸 바와 같이, 본 발명의 실시예 1 내지 6의 방부 조성물을 포함하는 섬유유연제 조성물의 경우, 3일차에서 모든 세균, 진균류가 사멸율이 99.9%이상으로 우수하였으나, 비교예 1 내지 2의 섬유유연제 조성물에서는 세균, 진균류에 대한 항균력이 미흡하여 7일차에서도 완전히 사멸이 되지 않았다. 따라서, 섬유유연제에서도 본 발명의 SDS와 CPC를 특정 비율로 혼합하여 사용하는 경우, 각각 한가지 성분만 사용하는 경우보다 더욱 우수한 항균 및 항진균 효과를 갖는 방부 조성물을 제조할 수 있음을 확인 하였다. 특히 실시예 1 내지 2에서 2일차에서 진균이 모두 사멸하는 것을 확인하였다. As shown in Table 14, in the case of the fabric softener composition containing the antiseptic compositions of Examples 1 to 6 of the present invention, all bacteria and fungi were excellent in killing rate of 99.9% or more on the third day, but Comparative Examples 1 to In the fabric softener composition of 2, the antimicrobial activity against bacteria and fungi was insufficient, and thus did not die completely even on the 7th day. Therefore, it was confirmed that even when the fiber softener is used by mixing the SDS and CPC of the present invention at a specific ratio, it is possible to prepare an antiseptic composition having better antibacterial and antifungal effects than when only one component is used. In particular, in Examples 1 to 2 it was confirmed that all fungi are killed on the second day.
<< 실험예Experimental Example 7> 본 발명의 방부 조성물 함유한 산업용 기름때 제거제의 제조. 7> Preparation of industrial degreaser containing preservative composition of the present invention.
제조예 6에서 제조한 산업용 기름때 제거제의 항균 및 항진균 효과를 다음과 같은 방법으로 실험하였다. 본 발명 방부 조성물의 항균 및 항진균력 시험평가 방법으로는 ASTM D2574 법을 통해 목적물인 세제에 106 CFU/ml의 대장균(Escherichia coli), 106 CFU/ml의 황색포도상구균(Staphylococcus aureus), 106 CFU/ml의 녹농균(Pseudomonas aeroginosa)을 각각 혼합하여 streaking 하고, 초기, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였으며, 105 CFU/ml의 칸디다 알비칸스(candida albicans)와 흑곰팡이균(Aspergillus niger)도 각각 streaking 하고, 초기, 1일, 3일, 7일간 상온 조건에서 배양 후 결과를 관찰하였다. 대조군(control)은 본 발명의 방부 조성물 대신에 동량의 정제수를 첨가하여 제조예 6에 따라 제조한 산업용 기름때 제거제를 제조하여 사용하였고, 상기 시험 결과는 표 15에 나타내었다.The antibacterial and antifungal effects of the industrial degreaser remover prepared in Preparation Example 6 were tested in the following manner. As an antimicrobial and antifungal test evaluation method of the antiseptic composition of the present invention, 10 6 CFU / ml Escherichia coli , 10 6 CFU / ml Staphylococcus aureus , 10 6 CFU / ml Pseudomonas aeroginosa were mixed and streaking, respectively, and the results were observed after incubation at room temperature for the initial, 3 and 7 days, and 10 5 CFU / ml of candida albicans and black mold The bacteria ( Aspergillus niger ) were also streaking, and the results were observed after incubation at room temperature for the initial, 1, 3, and 7 days. A control was used to prepare an industrial degreaser removed according to Preparation Example 6 by adding the same amount of purified water instead of the preservative composition of the present invention, the test results are shown in Table 15.
표 15
경과일 시험균주 접종수 대조군 비교예1 실시예1 실시예2 실시예3 실시예4 실시예5 실시예6 비교예2
균주 (CFU/ml)
2일차 대장균 3.5 x 106 3 3 0 1 0 0 0 0 2
황색포도상구균 2.3x 106 3 3 1 1 1 1 0 0 2
녹농균 4.1 x 106 3 2 0 1 0 0 0 0 2
칸디다 알비칸스 1.9 x 105 3 3 1 1 1 1 0 0 3
흑곰팡이균 3.8 x 105 4 3 1 1 1 1 0 0 1
3일차 대장균 3.5 x 106 3 2 0 0 0 0 0 0 2
황색포도상구균 2.3x 106 2 1 0 0 0 0 0 0 1
녹농균 4.1 x 106 3 1 0 0 0 0 0 0 1
칸디다 알비칸스 1.9 x 105 2 2 0 0 0 0 0 0 2
흑곰팡이균 3.8 x 105 2 1 0 0 0 0 0 0 1
7일차 대장균 3.5 x 106 3 1 0 0 0 0 0 0 1
황색포도상구균 2.3x 106 2 1 0 0 0 0 0 0 1
녹농균 4.1 x 106 3 1 0 0 0 0 0 0 2
칸디다 알비칸스 1.9 x 105 2 1 0 0 0 0 0 0 1
흑곰팡이균 3.8 x 105 2 2 0 0 0 0 0 0 1
Table 15
Elapsed date Test strain Inoculation number Control Comparative Example 1 Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 2
Strain (CFU / ml)
Day 2 Escherichia coli 3.5 x 10 6 3 3 0 One 0 0 0 0 2
Staphylococcus aureus 2.3x 10 6 3 3 One One One One 0 0 2
Pseudomonas aeruginosa 4.1 x 10 6 3 2 0 One 0 0 0 0 2
Candida albicans 1.9 x 10 5 3 3 One One One One 0 0 3
Black fungus 3.8 x 10 5 4 3 One One One One 0 0 One
Day 3 Escherichia coli 3.5 x 10 6 3 2 0 0 0 0 0 0 2
Staphylococcus aureus 2.3x 10 6 2 One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 4.1 x 10 6 3 One 0 0 0 0 0 0 One
Candida albicans 1.9 x 10 5 2 2 0 0 0 0 0 0 2
Black fungus 3.8 x 10 5 2 One 0 0 0 0 0 0 One
Day 7 Escherichia coli 3.5 x 10 6 3 One 0 0 0 0 0 0 One
Staphylococcus aureus 2.3x 10 6 2 One 0 0 0 0 0 0 One
Pseudomonas aeruginosa 4.1 x 10 6 3 One 0 0 0 0 0 0 2
Candida albicans 1.9 x 10 5 2 One 0 0 0 0 0 0 One
Black fungus 3.8 x 10 5 2 2 0 0 0 0 0 0 One
0= No Contamination (Sterile)0 = No Contamination (Sterile)
1= Trace of contamination (1~9 Colonies per streak)1 = Trace of contamination (1 ~ 9 Colonies per streak)
2= Light contamination (10 ~ 99 Colonies per streak)2 = Light contamination (10 ~ 99 Colonies per streak)
3= Moderate contamination (Greater than 100 colonies but still distinguishable)3 = Moderate contamination (Greater than 100 colonies but still distinguishable)
4= Heavy contamination4 = Heavy contamination
상기 표 15에 나타낸 바와 같이, 본 발명의 실시예 1 내지 6의 방부 조성물을 포함하는 산업용 기름때 제거제 조성물의 경우, 3일차에서 모든 세균, 진균류가 사멸율이 99.9%이상으로 우수하였으나, 비교예 1 내지 2의 섬유유연제 조성물에서는 세균, 진균류에 대한 항균력이 미흡하여 7일차에서도 완전히 사멸이 되지 않았다. 따라서, 산업용 기름때 제거제에서도 본 발명의 SDS와 CPC를 특정 비율로 혼합하여 사용하는 경우, 각각 한가지 성분만 사용하는 경우보다 더욱 우수한 항균 및 항진균 효과를 갖는 방부 조성물을 제조할 수 있음을 확인 하였다.As shown in Table 15, in the case of the industrial degreaser composition containing the antiseptic compositions of Examples 1 to 6 of the present invention, all bacteria and fungi were excellent in killing rate of 99.9% or more on the third day, but Comparative Example 1 In the fabric softener composition of 2 to 2, the antimicrobial activity against bacteria and fungi was insufficient, and thus did not die completely even on the 7th day. Therefore, it was confirmed that even when the industrial oil degreaser was used by mixing the SDS and CPC of the present invention in a specific ratio, it was possible to prepare an antiseptic composition having better antibacterial and antifungal effects than when only one component was used.
특히 실시예 5 내지 6의 경우 2일차에서 세균과 진균이 모두 사멸하였다.In particular, in Examples 5 to 6, both bacteria and fungi were killed on Day 2.
<< 실험예Experimental Example 8> 본 발명의 방부 조성물의 안정성 확인  8> Confirmation of stability of antiseptic composition of the present invention
상기 표 2의 실시예 7 내지 10 및 상기 표 3의 실시예 11 내지 22과 같이, SDS, CPC, 소듐설파이트(Sodium sulfite), 헥실렌 글리콜(Hexylene Glycol) 및 각종 계면활성제를 포함하는 각 방부 조성물의 빙점 및 재결정 온도의 강하에 대한 효과를 확인하였다. As in Examples 7 to 10 of Table 2 and Examples 11 to 22 of Table 3, each preservative containing SDS, CPC, Sodium sulfite, Hexylene Glycol and various surfactants The effect on the freezing point of the composition and the drop in recrystallization temperature was confirmed.
100ml 용액에 대하여 냉각수로 온도를 강하하여 펄형태의 구름현상의 미세한 결정운이 생기는 온도(재결정온도)를 측정하였다. 이들의 결과는 하기 표 16에 나타내었다. The temperature (recrystallization temperature) of the fine crystal cloud of the cloud-shaped cloud phenomenon was measured by dropping the temperature with the cooling water with respect to the 100 ml solution. These results are shown in Table 16 below.
표 16
빙점OC 재결정 온도OC 빙점OC 재결정 온도OC
실시예7 2.0 10.0 실시예 15 -22.0 0.1
실시예8 -3.0 7.0 실시예 16 -21.0 0.3
실시예9 -11.0 6.0 실시예 17 -22.0 0.3
실시예10 -14.0 4.0 실시예 18 -23.0 0.1
실시예11 -15.0 2.0 실시예 19 -22.0 0.3
실시예12 -16.0 1.5 실시예 20 -22.0 0.2
실시예13 -16.5 1.0 실시예 21 -21.0 0.5
실시예 14 -20.0 0.5 실시예 22 -21.0 0.5
Table 16
Freezing Point O C Recrystallization temperature O C Freezing Point O C Recrystallization temperature O C
Example 7 2.0 10.0 Example 15 -22.0 0.1
Example 8 -3.0 7.0 Example 16 -21.0 0.3
Example 9 -11.0 6.0 Example 17 -22.0 0.3
Example 10 -14.0 4.0 Example 18 -23.0 0.1
Example 11 -15.0 2.0 Example 19 -22.0 0.3
Example 12 -16.0 1.5 Example 20 -22.0 0.2
Example 13 -16.5 1.0 Example 21 -21.0 0.5
Example 14 -20.0 0.5 Example 22 -21.0 0.5
상기 표 16에서와 같이, SDS와 CPC 만을 혼합하여 방부 조성물을 제조하는 것보다, 소듐설파이트, 헥실렌 글리콜, 계면활성제 및 이들의 조합으로 이루어진 군에서 선택되는 어느 하나를 혼합하여 방부 조성물을 제조하는 경우, 재결정 온도와 빙점이 낮아져, 안정성이 우수한 방부 조성물을 제조할 수 있음을 확인 하였다.As shown in Table 16, rather than mixing only SDS and CPC to prepare an antiseptic composition, by mixing any one selected from the group consisting of sodium sulfite, hexylene glycol, surfactants and combinations thereof to prepare an antiseptic composition In this case, it was confirmed that the recrystallization temperature and the freezing point were lowered to prepare an antiseptic composition having excellent stability.
<< 실험예Experimental Example 9> 본 발명의 방부 조성물의 피부 저자극 효과 확인 9> Confirm the skin hypoallergenic effect of the antiseptic composition of the present invention
본 발명의 방부 조성물의 피부에 대한 자극성을 조사하기 위하여 다음과 같은 실험하였다. 실시예 1 내지 22에 정제수를 포함하는 용액을 제조하고 핀 챔버(Finn chamber); NORGESPLASTER A/S, NORWAY의 페이퍼 디스크(Paper disc)에 10㎕씩 흡수시켜, 피검자(20명) 팔의 하박부에 48시간 부착시켰다. 핀 챔버(Finn chamber)를 제거하고 흐르는 물로 씻은 후 2시간 뒤, 피부의 발적을 조사하였으며, 그 결과는 표 17과 같다.In order to investigate the irritation to the skin of the antiseptic composition of the present invention was tested as follows. Prepare a solution containing purified water in Examples 1 to 22, Finn chamber (Finn chamber); 10 microliters were absorbed by NORGESPLASTER A / S and NORWAY paper disc, and it adhered to the lower part of arm of 20 subjects for 48 hours. After 2 hours after removing the Fin chamber (washing with running water), the redness of the skin was examined, the results are shown in Table 17.
표 17
구분 총피검자수/20명
++ + ± -
실시예 1 - - - 20
실시예 2 - - - 20
실시예 3 - - - 20
실시예 4 - - - 20
실시예 5 - - - 20
실시예 6 - - - 20
실시예 7 - - - 20
실시예 8 - - - 20
실시예 9 - - - 20
실시예 10 - - - 20
실시예 11 - - - 20
실시예 12 - - - 20
실시예 13 - - - 20
실시예 14 - - - 20
실시예 15 - - - 20
실시예 16 - - - 20
실시예 17 - - - 20
실시예 18 - - - 20
실시예 19 - - - 20
실시예 20 - - - 20
실시예 21 - - - 20
실시예 22 - - - 20
Table 17
division Total number of subjects / 20 people
++ + ± -
Example 1 - - - 20
Example 2 - - - 20
Example 3 - - - 20
Example 4 - - - 20
Example 5 - - - 20
Example 6 - - - 20
Example 7 - - - 20
Example 8 - - - 20
Example 9 - - - 20
Example 10 - - - 20
Example 11 - - - 20
Example 12 - - - 20
Example 13 - - - 20
Example 14 - - - 20
Example 15 - - - 20
Example 16 - - - 20
Example 17 - - - 20
Example 18 - - - 20
Example 19 - - - 20
Example 20 - - - 20
Example 21 - - - 20
Example 22 - - - 20
상기 표 17에 나타낸 바와 같이, 실시예 1 내지 22의 방부 조성물은 모두 피부 자극성이 없는 것으로 확인되었다.As shown in Table 17, all of the antiseptic compositions of Examples 1 to 22 were found to be not skin irritant.
이상, 본 발명의 일 실시예에 대하여 설명하였으나, 해당 기술 분야에서 통상의 지식을 가진 자라면 특허청구범위에 기재된 본 발명의 사상으로부터 벗어나지 않는 범위 내에서, 구성 요소의 부가, 변경, 삭제 또는 추가 등에 의해 본 발명을 다양하게 수정 및 변경시킬 수 있을 것이며, 이 또한 본 발명의 권리범위 내에 포함된다고 할 것이다.As mentioned above, although an embodiment of the present invention has been described, those of ordinary skill in the art may add, change, delete or add components within the scope not departing from the spirit of the present invention described in the claims. The present invention may be modified and changed in various ways, etc., which will also be included within the scope of the present invention.
본 발명의 방부 조성물은 제형이 수용액, 에멀전, 디스퍼전, 서스펜션 및 유용액 중에서 선택된 것 일 수 있고, 상기 방부 조성물은 물티슈용 조성물, 화장료 조성물, 샴푸 조성물, 세제용 조성물, 섬유유연제용 조성물, 산업용 세정제 조성물 등에 사용될 수 있다.The antiseptic composition of the present invention may be a formulation selected from an aqueous solution, an emulsion, a disperse, a suspension and a useful solution, the antiseptic composition is a wet wipes composition, cosmetic composition, shampoo composition, detergent composition, fabric softener composition, industrial It can be used in detergent compositions and the like.

Claims (20)

  1. 소듐 메타바이설파이트(Sodium Metabisulfite, SDS) 및 염화 세틸피리디늄(Cetylpyridinium chloride, CPC)을 중량비 1 : 0.2 내지 5로 포함하는 방부 조성물.Antiseptic composition comprising Sodium Metabisulfite (SDS) and Cetylpyridinium chloride (CPC) in a weight ratio of 1: 0.2 to 5.
  2. 제1항에 있어서, The method of claim 1,
    상기 방부 조성물은 소듐설파이트(Sodium Sulfite), 헥실렌글라이콜(Hexylene Glycol), 계면활성제 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것인, 방부 조성물. The antiseptic composition is sodium sulfite (Sodium Sulfite), hexylene glycol (Hexylene Glycol), and further comprising any one selected from the group consisting of surfactants, combinations thereof, antiseptic composition.
  3. 제2항에 있어서, The method of claim 2,
    상기 방부 조성물은 소듐설파이트의 경우 SDS와 소듐설파이트는 중량비 1 : 0.1 내지 1.5, 헥실렌글라이콜의 경우 SDS와 헥실렌글라이콜을 중량비 1 : 0.1 내지 1.5, 계면활성제의 경우 SDS와 계면활성제를 1 : 0.1 내지 300으로 포함하는 것인, 방부 조성물. The preservative composition is SDS and sodium sulfite in the case of sodium sulfite 1: 0.1 to 1.5 by weight, SDS and hexylene glycol in the weight ratio of 1: 0.1 to 1.5 for hexylene glycol, SDS and 1 to 0.1 to 300 of the surfactant, the antiseptic composition.
  4. 제2항에 있어서,The method of claim 2,
    상기 계면활성제는 카르본산염계, 황산에스테르염계, 설폰산염계 또는 인산에스테르염계의 음이온성 계면활성제; 폴리에틸렌글리콜계 또는 다가알코올계의 비-이온성 계면활성제; 및 아미노산계 또는 베타인계(Betaine)의 양쪽성 계면활성제인 것인 방부 조성물.The surfactant may be an anionic surfactant of carboxylate, sulfate ester salt, sulfonate salt or phosphate ester salt; Polyethylene glycol-based or polyhydric alcohol-based non-ionic surfactants; And amino acid-based or betaine-based amphoteric surfactants.
  5. 제1항 내지 제4항 중 어느 한 항에 있어서,The method according to any one of claims 1 to 4,
    상기 방부 조성물은 제형이 수용액, 에멀전, 디스퍼전(dispersion), 서스펜션(suspension) 및 유용액 중에서 선택된 것인, 방부 조성물. The antiseptic composition is an antiseptic composition, wherein the formulation is selected from aqueous solutions, emulsions, dispersions, suspensions and useful solutions.
  6. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 물티슈용 조성물.A wet wipe composition comprising the antiseptic composition according to any one of claims 1 to 4.
  7. 제6항에 있어서, The method of claim 6,
    상기 방부 조성물을 0.01 중량% 내지 10 중량%로 포함하는 것인, 물티슈용 조성물.The antiseptic composition comprising 0.01% by weight to 10% by weight, the composition for wet wipes.
  8. 제6항에 있어서,The method of claim 6,
    상기 물티슈용 조성물은 보습제, pH 조절제, 향료 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것인, 물티슈용 조성물. The composition for wet wipes further comprises any one selected from the group consisting of a moisturizer, a pH adjuster, a fragrance and a combination thereof, the composition for wet wipes.
  9. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 화장료 조성물.Cosmetic composition comprising the antiseptic composition according to any one of claims 1 to 4.
  10. 제9항에 있어서,The method of claim 9,
    상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함하는 화장료 조성물.Cosmetic composition comprising 0.1 to 10% by weight of the antiseptic composition.
  11. 제9항에 있어서,The method of claim 9,
    상기 화장료 조성물은 pH 조절제, 보습제, 향료, 계면활성제, 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것인, 화장료 조성물. The cosmetic composition further comprises any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, additives, purified water and combinations thereof.
  12. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 샴푸 조성물.A shampoo composition comprising the antiseptic composition according to any one of claims 1 to 4.
  13. 제12항에 있어서,The method of claim 12,
    상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함하는 것인, 샴푸 조성물.Shampoo composition comprising 0.1 to 10% by weight of the antiseptic composition.
  14. 제12항에 있어서,The method of claim 12,
    상기 샴푸 조성물은 pH 조절제, 보습제, 향료, 계면활성제, 첨가제, 정제수 및 이들의 조합으로 이루어진 군에서 선택된 어느 하나를 더 포함하는 것인, 샴푸 조성물.The shampoo composition further comprises any one selected from the group consisting of pH adjusters, moisturizers, fragrances, surfactants, additives, purified water and combinations thereof.
  15. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 세제용 조성물.Detergent composition comprising an antiseptic composition according to any one of claims 1 to 4.
  16. 제15항에 있어서,The method of claim 15,
    상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함하는 것인, 세제용 조성물.Containing the antiseptic composition 0.1 wt% to 10 wt%, detergent composition.
  17. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 섬유유연제용 조성물.A composition for fabric softener comprising the antiseptic composition according to any one of claims 1 to 4.
  18. 제17항에 있어서,The method of claim 17,
    상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함하는 것인, 섬유유연제용 조성물.The antiseptic composition comprises 0.1 wt% to 10 wt%, the composition for fabric softener.
  19. 제1항 내지 제4항 중 어느 한 항에 따른 방부 조성물을 포함하는 산업용 세정제 조성물.An industrial detergent composition comprising the antiseptic composition according to any one of claims 1 to 4.
  20. 제19항에 있어서,The method of claim 19,
    상기 방부 조성물을 0.1 중량% 내지 10 중량%로 포함하는 것인, 산업용 세정제 조성물.Industrial preservative composition comprising from 0.1% to 10% by weight of the antiseptic composition.
PCT/KR2015/004678 2014-12-15 2015-05-11 Antiseptic composition and use thereof WO2016098965A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020177014904A KR20170087469A (en) 2014-12-15 2015-05-11 Antiseptic composition and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0180191 2014-12-15
KR20140180191 2014-12-15

Publications (1)

Publication Number Publication Date
WO2016098965A1 true WO2016098965A1 (en) 2016-06-23

Family

ID=56126820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/004678 WO2016098965A1 (en) 2014-12-15 2015-05-11 Antiseptic composition and use thereof

Country Status (2)

Country Link
KR (1) KR20170087469A (en)
WO (1) WO2016098965A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113073015A (en) * 2021-02-25 2021-07-06 郑州百瑞动物药业有限公司 Sterilization and deodorization laundry detergent for pets and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027436A1 (en) * 1993-05-20 1994-12-08 Decicco Benedict T Preservative systems with enhanced antimicrobial activity
WO2000065911A1 (en) * 1999-04-30 2000-11-09 Sintal International, Inc. Anti-bacterial composition and use thereof for skin care and fabric treatment
JP2003079530A (en) * 2001-09-12 2003-03-18 Uni Charm Corp Wet tissue
KR101195724B1 (en) * 2011-11-29 2012-10-29 보령메디앙스 주식회사 Preservative composition and article comprising the same
KR20130082399A (en) * 2012-01-11 2013-07-19 (주)에스피산업 Composition of preservative for water tissue

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027436A1 (en) * 1993-05-20 1994-12-08 Decicco Benedict T Preservative systems with enhanced antimicrobial activity
WO2000065911A1 (en) * 1999-04-30 2000-11-09 Sintal International, Inc. Anti-bacterial composition and use thereof for skin care and fabric treatment
JP2003079530A (en) * 2001-09-12 2003-03-18 Uni Charm Corp Wet tissue
KR101195724B1 (en) * 2011-11-29 2012-10-29 보령메디앙스 주식회사 Preservative composition and article comprising the same
KR20130082399A (en) * 2012-01-11 2013-07-19 (주)에스피산업 Composition of preservative for water tissue

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113073015A (en) * 2021-02-25 2021-07-06 郑州百瑞动物药业有限公司 Sterilization and deodorization laundry detergent for pets and preparation method thereof

Also Published As

Publication number Publication date
KR20170087469A (en) 2017-07-28

Similar Documents

Publication Publication Date Title
EP0914085B1 (en) Concentrated liquid accumulations comprising a microbicidally active ingredient
JP3625214B2 (en) Antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant
US8236357B2 (en) Mild composition for skin disinfection
US20030235550A1 (en) Antimicrobial compositions, products and methods employing same
US20090215854A1 (en) Antimicrobial compositions, products and methods employing same
US20070105741A1 (en) Disinfectant compositions and methods of use thereof
RU2712186C1 (en) Surface disinfection method and composition suitable for use in disinfecting surface
KR101195724B1 (en) Preservative composition and article comprising the same
US8629180B2 (en) Antiseptic agent composition
KR101500514B1 (en) Wet Tissue Containing Antiseptic Composition without Skin Irritation
JP5346455B2 (en) Antibacterial detergent composition
DE69823187T2 (en) A COMPOSITION COMPRISING AN N-ANDECYLENOYL AMINO-SUBSTRATE; APPLICATION IN COSMETICS
WO2018143520A1 (en) Ear cleaning solution for companion animal and preparation method therefor
KR102348162B1 (en) Composition of anti bacterial containing Zophobas morio oil
WO2016098965A1 (en) Antiseptic composition and use thereof
KR20100078777A (en) Rapid antifungal handwash composition
KR100425943B1 (en) Germicide with the skin care of lotion type
US20080070986A1 (en) Alkylether citrates for selectively cleaning the skin
KR101086926B1 (en) Disinfectant composition for hand including mastic
KR20170115791A (en) Non-irritating antibacterial composition comprising natural ingredients and sanitary articles containing thereof
KR101476093B1 (en) A composition for water tissue containing Piroctone olamine
KR102141128B1 (en) composition for eyelid or periocular region washing and pad comprising thesame
CA2832490C (en) Compositions for internal and external insecticides, ovicides, repellents and wound healing
KR101320599B1 (en) Antiseptic free and anti-biotic wet tissue
JPH0536404B2 (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15870133

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20177014904

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15870133

Country of ref document: EP

Kind code of ref document: A1